Fruit Polyphenols and their Fate in the Mammalian System after Ingestion by Gasperotti , Mattia
  
International Doctoral School in Biomolecular Sciences 
XXVI Cycle 
 
 
 
 
Fruit Polyphenols and their Fate  
in the Mammalian System after Ingestion  
 
 
 
 
 
Tutor:  Dr. Fulvio Mattivi,  
  Department of Food Quality and Nutrition, Fondazione E. Mach 
Advisors:  Dr. Urska Vrhovsek, 
  Department of Food Quality and Nutrition, Fondazione E. Mach 
  Prof. Graziano Guella, 
Department of Physics, University of Trento 
 
 
Ph.D. Thesis of 
Mattia Gasperotti 
Centre for Integrative Biology (CIBIO), University of Trento 
Department of Food Quality and Nutrition, Fondazione E. Mach (FEM)  
 
Academic Year 2012-2013 
  
  
Ph.D. Thesis Abstract: 
 
 A range of different polyphenols can be ingested in a bowl of 
polyphenol-rich fruit, going from one-phenol hydroxybenzoic acid to more complex 
polymeric compounds. Epidemiologically, polyphenol consumption has been 
associated with a reduced risk of cancer and cardiovascular disease and neurological 
protection against brain ageing. However, only a small proportion of native 
polyphenols (5-10%) are absorbed and the remainder reach the colon, where they are 
extensively metabolised by the gut microbiota. The colonic microbiota produces a 
relatively small number of polyphenol microbial metabolites from a large number of 
different dietary polyphenols. During subsequent tissue distribution, the target 
organs and the effective concentration circulating remain largely unreported. 
 This Ph.D. thesis is divided into two parts: chemical analysis of food 
composition and in vivo bioavailability of polyphenol metabolites. Metabolomics 
offers an innovative approach that has recently been shown to be effective in both 
food chemistry and nutritional bioavailability studies. 
 Polyphenol composition in strawberries is studied in the first part of this Ph.D. 
thesis, with the aim of evaluating nutritionally significant amounts of polyphenols 
before ingestion. In this context, a targeted method for quantitative analysis of 
multiple classes of phenols was developed. A high sensitivity MRM-based method 
for 135 phenolics with a wide dynamic range was obtained, providing valuable 
insight and assisting with the analysis of complex matrices such as fruit, and more in 
general food.  
 Application of the method was tested in Fragaria spp., and along with another 
rapid method for the analysis of anthocyanins and ellagitannins, provided a general 
overview of polyphenol composition in strawberries. A total of 56 individual 
compounds were accurately identified and quantified, some of them for the first time, 
their concentration ranging from 1 ug/100 g for low abundant polyphenols to 40 
  
mg/100 g of fresh fruit. Moreover the isolation of some ellagitannins and definition of 
their profile in Fragaria spp. was carried out during fruit ripening. Clarification of the 
main ellagitannin, agrimoniin, was obtained by isolation and it was ambiguously 
assigned as the main ellagitannin present in the diet. 
In the second part of this Ph.D. thesis the in vivo bioavailability of a dose of 
polyphenol microbial metabolites reflecting dietary consumption of fruit was studied. 
The focus was on the metabolites of polyphenols which can be found in the 
bloodstream after gut microflora metabolism. Their distribution was explored in rats 
in different organs, in particular in the brain, considering their possible 
neuropreventive properties. Development of a specific quantitative method for the 
quantification of selected polyphenol microbial metabolites made it possible to 
analyse complex biological samples resulting from in vivo trials with rats treated with 
a nutritionally significant dose of polyphenol microbial metabolites, intravenously 
injected. A high-throughput, sensitive and reproducible method for 23 polyphenol 
metabolites in six different biological matrices was developed. A purification protocol 
made it possible to obtain cleaner and more concentrated samples, with low limits of 
quantification. Specific organ-tropism was observed, mainly hepatotropism.  
Remarkably, in this study the brain was reported to be one of the target organs 
for these molecules, already being present at basal level or increasing their 
concentration after treatment. Furthermore, the amount of 10 out of 23 compounds 
significantly increased with a nutritionally significant dose. 
  
 
 
 
 
 
 
 
Der Mensch ist, was er ißt 
(Man is what he eats) 
 
Ludwig A. Feuerbach (1804-1872) 
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Introduction and 
literature overview 
 
 
 
Polyphenols, gut microflora metabolism and 
their effects on human health 
 
 
 
 
 
 
This introduction has been adapted* and improved, including the relevant parts, 
from:  
Up-regulating the Human Intestinal Microbiome Using Whole Plant Foods, Polyphenols, 
and/or Fiber Kieran M. Tuohy, Lorenza Conterno, Mattia Gasperotti, and Roberto 
Viola Journal of Agricultural and Food Chemistry 2012 60 (36), 8776-8782  
 
Attached as an original paper after this introduction. 
 
*Adapted and reprinted with the permission of the Journal of Agricultural and Food Chemistry. 
Copyright © 2012 American Chemical Society 
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Epidemiologically, fruits and vegetables protect against chronic diseases 
including cardiovascular disease, cancer, obesity, and diabetes. Plant secondary 
polyphenolic compounds are thought to contribute significantly to the underlying 
protective processes (1-3). Interestingly, polyphenols potentially interact with the gut 
microbiota: for many polyphenols microbial transformation modifies bioavailability 
and activity. 
Plant polyphenols are a class of chemically diverse secondary metabolites that 
carry out many different biological activities both in plants and the animals which eat 
them (4). Mainly because of their presence in foods and medicinal plants, they have 
been studied at length, due to interaction with mammalian physiological processes 
that play a role in chronic human disease. As well as being antioxidants and 
possessing inherent free radical scavenging abilities, plant polyphenols have the 
potential to affect certain risk factors for cardiovascular disease, such as plasma lipid 
oxidation state, endothelial function and platelet aggregation; they protect against 
cancer by reducing DNA damage, cell proliferation, and metastasis; they modulate 
immune function; they inhibit bacterial pathogens and protect against neurological 
decline (see Figure 1). Most of the evidence relating to these effects on health stems 
from animal studies using either whole plant foods or plant polyphenol extracts. 
Consequently, both the active chemical moiety, and in many cases the underlying 
mechanism of action in humans, have yet to be determined (4).  
 
 
Figure 1 Diagram illustrating the direct intestinal effects 
of plant food polyphenols. 
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Human Gut Microbiota 
 
 The human gut microbiota is a diverse collection of microorganisms making 
up some 1000 species, with each individual having their own unique collection of 
species. These microorganisms play an important role in human health and disease, 
and inter-individual variation in microbiota makeup influences the profile of 
metabolites released from dietary components that reach the colon and may also 
affect an individual's risk of chronic disease. Recent studies have identified a limited 
number of “enterotypes” within the human gut microbiota, characterised by a 
predominance of Prevotella, Bacteroides and/or Ruminococcus (5,6). 
Moreover, these enterotypes appear to be determined by long-term diet and 
could play an important role in an individual's risk of developing chronic diet-
associated diseases such as obesity, metabolic syndrome and certain cancers (6). 
Different profiles of gut bacteria have also been characterised in populations with 
chronic immune or metabolic-related diseases, including inflammatory bowel disease 
(IBD), celiac disease, diabetes and obesity (7, 8). Typically, these conditions show a 
lower prevalence of beneficial butyrate-producing bacteria, such as Faecalibacterium 
prausnitzii, and the bifidobacteria, which appear to be indicative of a well-functioning, 
healthy saccharolytic type microbiota. These diseases are also often associated with a 
high prevalence of Enterobacteriaceae, a phylum that includes many important 
gastrointestinal pathogens including Escherichia coli, Shigella, Salmonella, Campylobacter 
and Helicobacter. These diseases are also often associated with increased intestinal 
permeability or “leaky gut”, a process that appears to be regulated both by diet and 
by gut microbiota-associated characteristics. 
Works on germ-free animals, animal models of obesity and the metabolic 
syndrome, and a limited number of human studies have shown that the gut 
microbiota of obese individuals differs from that of lean individuals. The obese 
appear to be typified by a gut microbiota with a reduced Bacteroidetes/Firmicutes ratio 
Mattia Gasperotti, Ph.D. Thesis 
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and perturbations within important fibre-degrading saccharolytic populations (11). 
Indeed, this obese type microbiota has been shown to revert to a lean type profile 
with increased relative abundance of the Bacteroidetes when obese individuals lose 
weight on low-energy diets. Such microbiota compositional differences within the 
obese, and other disease states, are likely to have a dramatic impact on the colonic 
metabolic output and subsequent physiological processes in the host, including 
control of food intake, inflammation, energy storage and energy expenditure (see 
Figure 1) (11). Certain shifts or profiles for gut bacteria are associated with poor diet, 
diets low in whole plant foods such as fruits and vegetables. Similar profiles for gut 
bacteria are also observed in chronic diseases related to affluent Western lifestyles, 
such as obesity, metabolic syndrome, certain cancers and autoimmune diseases such 
as IBD.  
Both the type and quantity of foods that escape digestion in the upper gut 
have an important impact on the composition and therefore, activity of the colonic 
microbiota. As much as 90% of plant polyphenols escape digestion and absorption in 
the upper gut and persist in the colon. Here they come into contact with the gut 
microbiota, acting as substrates for microbial production of small phenolic acids and 
SCFA, or indeed affecting species composition and their metabolic activity. 
 
Polyphenols and the Human Gut Microbiota 
 
As previously mentioned, after the consumption of food rich in polyphenols, 
more than 90 % of plant polyphenols escape digestion and absorption in the upper 
gut and reach the colon. Hydrolysis by the gut microbiota can increase the 
bioavailability and possibly the biological activity of polyphenols reaching the colon. 
The human intestinal microbiota has extensive hydrolytic activities and breaks down 
many complex polyphenols into smaller phenolic acids, which can be absorbed across 
the intestinal mucosa. These polyphenol catabolites are only then available to exert 
their biological activities systemically within the host. However, to date, with the 
  Introduction and Literature Overview 
   
   
5 
exception of a few compounds such as the phyto-estrogens equol, enterolactone and 
enterodiol, very little is known about the biological activities of phenolic acids 
deriving from microbiota polyphenol metabolism (2, 3). Table 1 presents some 
examples of parent plant polyphenols, microbial catabolites and their potential 
biological effect when known. Given the diversity of plant polyphenols, their possible 
microbial catabolites and the fact that they occur as mixtures in whole plant foods or 
plant extracts, only a small number of well-studied polyphenols are presented. 
Biological activities have not been described for most of the small phenolic acid 
catabolites, but common activities recognised so far include antibacterial activities, 
especially against Gram-negative species such as Enterobacteriaea, anti-inflammatory 
activities, anti-AGE formation, stimulation of xenobiotic degrading enzymes and 
detoxification processes and phyto-estrogenic activities. 
Recently, Miene et al. (13) demonstrated that microbial metabolites of 
quercetin and chlorogenic acid/caffeic acid, 3,4-dihydroxyphenylacetic acid (ES), and 
3-(3,4-dihydroxyphenyl) propionic acid (PS) respectively, could significantly up-
regulate GSTT2 expression and decrease COX-2 expression, a modulation seen as 
protective against colon cancer, and at the same time reduce DNA damage using an 
intestinal cancer cell line. González-Sarrı as et al. (14) showed that ellagic acid (EA) 
and its colonic metabolites, urolithin-A (3,8-dihydroxy-6H-dibenzo[b,d]pyran-6-one, 
Uro-A) and urolithin-B (3-hydroxy-6H-dibenzo[b,d]pyran-6-one, Uro-B), modulate 
the expression and activity of CYP1A1 and UGT1A10 and inhibit several 
sulfotransferases in colon cancer cell lines (Caco-2). These phase I and phase II 
detoxifying enzymes are important components of how our bodies deal with toxic 
and xenobiotic compounds, and increased expression is associated with a reduced 
risk of colon cancer in laboratory animals. However, these effects appeared to be 
critically affected by the food matrix in the rat colon. Nevertheless, urolithins from 
pomegranate have already been shown to reduce the growth of cancer cells in an 
animal model of prostate cancer (15). 
3,4-dihydroxyphenylpropionic acid (3,4-DHPPA), 3-hydroxyphenylpropionic 
acid, and 3,4-dihydroxyphenylacetic acid (3,4-DHPAA), derived from colonic 
Mattia Gasperotti, Ph.D. Thesis 
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catabolism of proanthocyanidins, have been shown to reduce the inflammatory 
response of human peripheral blood mononuclear cells stimulated with 
lipopolysaccharide (LPS), an inflammatory cell wall component from Gram-negative 
bacteria such as the Enterobacteriaceae. Secretion of IL-6, IL-1, and TNF-α was 
reduced, suggesting that microbial metabolites may be involved in dampening the 
inflammatory response to bacterial antigens, which may have implications for chronic 
inflammatory or autoimmune diseases such as IBD.(16) On screening 18 microbial 
catabolites of polyphenols for their anti-inflammatory potential in vitro, Larrosa et al. 
(17) found that hydrocaffeic (HCAF), dihydroxyphenylacetic (dOHPA) and 
hydroferulic acid (HFER) reduced prostaglandin E(2) production by at least 50% in 
CCD-18 colon fibroblast cells stimulated with IL-1β. The same compounds were also 
shown to reduce inflammation in rodents, and HCAF was also shown to reduce 
intestinal inflammation in the DSS-mouse model of ulcerative colitis with reduced 
mucosal expression of cytokines IL-1β, IL-8, and TNF-α, reduced malonyldialdehyde 
(MDA) levels, and decreased oxidative DNA damage (measured as 8-oxo-2′-
deoxyguanosine levels). Radnai et al. (18) also showed that ferulaldehyde, a microbial 
catabolite of curcumin, has anti-inflammatory properties in vivo in an animal model 
of LSP-induced septic shock. Intraperitoneal injection of ferulaldehyde (6 mg/kg) 
reduced markers of inflammation and prolonged the lifespan of LPS-treated animals, 
indicating that microbial catabolites might, at least in part, account for the observed 
anti-inflammatory activity of certain herbal medicines and functional foods. 
Microbial catabolites of plant polyphenols may also affect disease risk in 
metabolic syndrome, a cluster of biomarkers associated with obesity and increased 
risk of cardiovascular disease and diabetes. Verzelloni et al. (19) demonstrated that 
urolithins and pyrogallol, microbial ellagitannin-derived catabolites, are highly 
antiglycative compared to parent polyphenolic compounds in an in vitro model of 
protein glycation. Protein glycation plays an important pathological role in diabetes 
and pathologies associated with diabetes, including blindness. They also found that 
chlorogenic acid-microbially derived catabolites, dihydrocaffeic acid, dihydroferulic 
acid and feruloylglycine, were most effective at protecting cultured neural cells in 
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vitro, indicating that colonic catabolites of dietary polyphenols may play an important 
role in the improved cognitive function and protection from neuronal degeneration 
observed in animals fed polyphenol-rich foods such as certain berries. 
Plant polyphenols have also been shown to have a direct effect on 
carbohydrate fermentation by the human gut microbiota in vitro. Using anaerobic 
faecal batch cultures, Bazzocca et al. (20) found that apple proanthocyanidins 
inhibited both metabolic degradation of short proanthocyanidins and SCFA 
production. This observation may apparently suggest that polyphenols might work 
against production of beneficial microbial metabolites within the colon. As mentioned 
above, in individuals on a Western style, low-fibre diet, the proximal colon is the 
main site of saccharolytic fermentation, with potentially damaging proteolytic 
fermentation increasing distally as the carbohydrate substrate becomes limiting. 
Retardation of carbohydrate fermentation in the proximal colon may extend SCFA 
production to the distal colon, thereby reducing the harmful effects of amino acid 
catabolites. However, this remains to be investigated either in vivo or using complex 
multistage continuous culture models of the colonic microbiota. Similarly, 
polyphenols have also been shown to directly affect the relative abundance of 
different bacteria within the gut microbiota, with tea polyphenols and their 
derivatives reducing numbers of potential pathogens including Clostridium perfringens 
and C. difficile and certain Gram-negative Bacteroides spp., with less inhibition toward 
beneficial clostridia, bifidobacteria, and lactobacilli (21). 
 
Table 1 Examples of important plant polyphenols and their microbial catabolitesa 
 
plant polyphenol microbial catabolite possible health effects 
4-hydroxyphenylacetic acid antimicrobial/antimycotic activity in vitro 
3-(3-hydroxyphenyl)propionic acid 
antimicrobial activity against Gram-negative 
enterobacteria via outer membrane destabilization 
5-(3,4-dihydroxyphenyl)-γ-valeric acid   
(−)-epicatechin (29-31) 
(−)-5-(3′,4′-dihydroxyphenyl)-γ-
valerolactone 
  
4-hydroxyphenylacetic acid antimicrobial/antimycotic activity in vitro 
(−)-epigallocatechin (31) (−)-5-(3′,4′-dihydroxyphenyl)-γ-
valerolactone 
  
(−)-epigallocatechin-3-O- pyrocatechol   
Mattia Gasperotti, Ph.D. Thesis 
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plant polyphenol microbial catabolite possible health effects 
pyrogallol 
antibacterial activity (especially against Gram-
negative enterobacteria), acetylcholinesterase 
inhibition greater than gallic acid parent; inhibition 
of Vibrio spp. quorum sensing 
4-hydroxyphenylacetic acid antimicrobial/antimycotic activity in vitro 
gallate (29-34) 
(−)-5-(3′,4′-dihydroxyphenyl)-γ-
valerolactone 
  
hydrocaffeic acid 
dihydroxyphenyl acetic acid chlorogenic acid (17) 
hydroferulic acid 
reduced intestinal mucosal inflammation and 
oxidative damage in animal models of IBD 
3,4-dihydroxyphenylpropionic acid 
3-hydroxyphenylpropionic acid proanthocyanidins (16) 
3,4-dihydroxyphenylacetic acid 
reduced inflammatory response from LPS-
stimulated blood lymphocytes 
curcumin (18) ferulaldehyde 
reduced inflammatory response from LPS-
stimulated blood lymphocytes 
daidzein (35-37) equol 
phytoestrogen important for heart and bone health 
and possible colon cancer protectants 
daidzein (17, 33) O-demethylangolensin estrogenic and/or antiestrogenic activity 
2-(3,4-dihydroxyphenyl)acetic acid   
2,3-(3-hydroxyphenyl)acetic acid   
3,4-dihydroxybenzoic acid   
phloroglucinol   
3-(3,4-dihydroxyphenyl)propionic acid   
quercetin (33) 
3-(3-hydroxyphenyl)propionic acid   
kaempferol (33) 2-(4-hydroxyphenyl)acetic acid   
3-(4-hydroxyphenyl)propionic acid 
antimicrobial activity against Gram-negative 
enterobacteria via outer membrane destabilization naringenin (33) 
phloroglucinol   
isoxanthohumol (33) 8-prenylnaringenin   
3-(3-hydroxyphenyl)propionic acid   
5-(3′,4′-dihydroxyphenyl)-γ-valerolactone   
5-(3′-hydroxyphenyl)-γ-valerolactone   
3-hydroxyhippuric acid pyrogallol   
5-(3,4-dihydroxyphenyl)valeric acid   
5-(3-hydroxyohenyl)valeric acid   
3-(3,4-dihydroxyphenyl)propionic acid 
antimicrobial activity against Gram-negative 
enterobacteria via outer membrane destabilisation 
5-(3-methoxyohenyl)valeric acid   
3-(3,4-dihydroxyphenyl)propionic acid   
5-(3-methoxyohenyl)valeric acid   
catechin and epicatechin (24, 
33) 
2,3-dihydroxyphenoxyl 3-(3′,4′-
dihydroxyphenyl)propionic acid 
  
urolithin-A 
estrogenic and/or antiestrogenic activity, 
antimalarials, induction of detoxification enzymes 
urolithin-B 
estrogenic and/or antiestrogenic activity, 
antimalarials, induction of detoxification enzymes 
urolithin-C estrogenic and/or antiestrogenic activity 
ellagitannins/ellagic acid (3, 
14, 17, 34) 
urolithin-D estrogenic and/or antiestrogenic activity 
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plant polyphenol microbial catabolite possible health effects 
3-hydroxyphenylacetic acid 
rutin and catabolites inhibit AGE formation in 
vitro; antimicrobial activity against Gram-negative 
enterobacteria via outer membrane destabilisation 
3,4-dihydroxybenzoic acid   
4-hydroxybenzoic acid   
3-(3-hydroxyphenyl)propionic acid   
rutin (24, 35, 36) 
3,4-dihydroxyphenylacetic acid   
enterolactone 
Phytoestrogen important for heart and bone health; 
possible colon cancer protectants 
lignans (28) 
enterodiol 
Phytoestrogen important for heart and bone health; 
possible colon cancer protectants 
a The putative health effects of selected catabolites are also presented. 
 
Human data on the impact of polyphenols on the gut microbiota are scarce. 
One recent work from the University of Reading has shown that a high cocoa-
flavanol (494 mg/day) drink can mediate prebiotic type modulation of the gut 
microbiota in a randomised intervention study compared to a low cocoa-flavanol (23 
mg/day) drink. The high-flavanol drink resulted in significant increases in faecal 
bifidobacteria and lactobacilli and a reduction in clostridial counts and a concomitant 
reduction in plasma triglycerides and C-reactive protein, both important markers of 
metabolic disease (22). These results were mirrored by previous in vitro studies using 
faecal batch cultures by the same group (23). 
 
Polyphenol Microbial Metabolites and the Brain  
 
The biological properties of polyphenol microbial metabolites have been little 
explored and reported in the literature, mostly in relation to their neurological 
relevance and brain ageing prevention. Many experiments have been done on in vitro 
models, while evidences from in vivo systems are rare.  
Dietary intervention and epidemiological studies on humans have concluded 
that polyphenols and their metabolites may have some involvement in neurological 
protection/prevention and may promote brain health (37). The phenolic structure 
could protect against oxidative stress and their activity could be exerted at local or 
Mattia Gasperotti, Ph.D. Thesis 
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systemic levels (33). However, antioxidant protection does not seem to be enough in 
predicting and assessing the bioactivity of these metabolites against certain disorders 
affected by ageing, and as a consequence other mechanisms of actions could be 
involved in neurological protection. Other mechanisms of action resulting in the 
literature are: direct effects on signalling to promote neuronal communication, the 
ability to buffer against calcium, enhancement of neuroprotective stress shock 
proteins and reduction of any stress signals (38). Recently mitochondrial dysfunction 
has also received attention in the pathogenesis of neurodegenerative diseases and 
brain ageing. Mitochondria are often considered as both initiators and targets of 
oxidative stress, during which polyphenol metabolites could modulate mitochondrial 
functions (39). 
However, it has not yet been clearly established whether these compounds 
reach the brain in a sufficient concentration and there are little information about the 
kind of interaction between polyphenols or their metabolites and the blood brain 
barrier (40). Moreover, reliable data on uptake into the brain are limited and with 
ambiguous protocols or data acquisition (41). 
The blood brain barrier is made up of brain capillary endothelial cells and 
other different cell types, such as perycytes, astrocytes and neuronal cells. A 
mandatory requisite for any kind of activity in the brain is therefore that polyphenol 
metabolites and their conjugates are able to pass the blood brain barrier and enter the 
brain. Many aspects limit brain permeability, brain capillary and endothelial cells 
having tight junctions which prevent paracellurar transport of water-soluble 
compounds. Transcellular transport is also limited. Possibly for these reasons, most 
experiments reporting on biological activities and the targets of polyphenols or their 
metabolites have used in vitro experiments, which are prone to artefact or not in line 
with real complex situations involving the brain and the blood brain barrier (39). 
The bioactivity of selected polyphenol metabolites in vitro has been tested at 
physiologically relevant doses against advanced glycation endproduct formation and 
the ability to counteract mild oxidative stress on human neuronal cells (19). All the 
catabolites investigated, divided into groups correlated with the consumption of 
  Introduction and Literature Overview 
   
   
11 
raspberries/pomegranates, coffee or berries/red wine have shown antiaglycane 
activity. Urolithin A and B, for example, from the microbial metabolism of 
ellagitannins, significantly reduced protein glycation at 1 µmol/L. In a vitro cell 
system with PC12 cells, protocatechuic acid has been shown to decrease 
mitochondrial dysfunction (42). Protocatechuic acid, the main microbial metabolite of 
anthocyanins, has been detected in human and animal blood, but at the moment there 
is no information available regarding brain uptake. 
The presence of gallic acid in the brain in vivo was shown in one interesting 
paper involving rats after the administration of proanthocyanidins (43). Gallic acid 
and some other methylated metabolites were observed inside the brain, albeit in trace 
amounts.  
Research on the effects of polyphenol metabolites in the future must involve 
in vivo models or artefact-free in vitro experiments and testing at physiological 
concentrations (39). In order to obtain more realistic observations, it is important to 
carry out experiments starting from the plasma concentration of these metabolites, 
which are in the range of sub-uM or nM in normal dietary consumption. 
Furthermore, the bioavailability of polyphenol microbial metabolites has to be 
carefully taken into account in nutrition-based studies and brain ageing experiments, 
along with the already investigated bioavailability of native polyphenols in plants. 
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 Recently, numerous studies have suggested that a wide range of polyphenols 
and their metabolites may have neuroprotective effects both in vitro and in vivo. 
Berries and strawberries are certainly among the best examples of “superfruit” with 
proven positive healthy effects.  In order to correctly evaluate the nutritional impact 
of fruit consumption it is first important to assess the precise composition of fruit 
polyphenols. In this study strawberries were chosen, as they are the most widely 
consumed type of soft fruit. Furthermore, it was necessary to prove whether these 
compounds can reach the brain in sufficient concentrations and in biologically active 
forms in order to exert beneficial effects.  
 
 The aim of my project was to study the effects of fruit consumption on the 
mammalian system and it was designed to cover two complementary fields of 
research: food chemistry and nutritional bioavailability. With the growing interest in 
the use of metabolomics, a wide range of biological targets and food applications 
related to nutrition and quality are rapidly emerging, offering the opportunity to gain 
deeper insight into several fields of research. A better knowledge of which types of 
polyphenols affect the mammalian metabolism can be achieved with the 
implementation of well-designed metabolomics experiments with different targets.  
 Accurate knowledge about the content of compounds important in the human 
diet in terms of polyphenols and their bioavailability is still not available, therefore 
the final goal of the study was to provide a substantial improvement in 
understanding the relevance of a diet rich in polyphenols to health. 
   
The thesis, gathering together the main results published and manuscripts 
about to be published, is divided into these two fields of research. Each publication or 
manuscript is introduced by a brief overview of the literature and the scope and the 
main results obtained, along with a precise statement of my personal involvement in 
the work.  
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In the food chemistry section, Chapter 1.1 presents a targeted metabolomics 
method for the detection of several classes of polyphenols in a short chromatographic 
run, while in Chapter 1.2 the attention was focused on a precise class of polyphenols 
also present in the strawberry: ellagitannins. The objective was to identify and clarify 
the chemical structures of the main ellagitannins in the strawberry, followed by their 
isolation and precise characterisation. Moreover in a second publication, further 
abundant ellagitannins were isolated and overall ellagitannin profiling with high 
definition mass spectrometry was performed, along with their quantification. Chapter 
1.3 instead combines the results presented in the previous chapters with the precise 
polyphenolic composition of a bowl of strawberries, presented for the first time. 
 
In the nutritional bioavailability section, Chapter 2.1 presents the development 
of a targeted metabolomics method for the detection of 23 polyphenol microbial 
metabolites in different organs of rats, i.e. blood, brain, liver, kidneys, heart and 
urine. Chapter 2.2 instead brings together the results of an in vivo experiment tracing 
the fate of 23 polyphenol microbial metabolites in rats, primarily in the brain but also 
in other organs, resulting from the putative consumption of a bowl of strawberries. 
The main goal was to prove whether these metabolites can reach the brain, 
supporting their ability to promote neuroprevention of brain ageing and neurological 
disease, as reported in epidemiological studies or in vitro experimentation. 
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Food Chemistry 
Chapter 1.1 
 
 
 
A targeted metabolomics method for the rapid 
quantification of multiple classes of phenolics  
 
 
 
 
 
 
 
 
 
 
 
This chapter has been reprinted* from:  
 
A Versatile Targeted Metabolomics Method for the Rapid Quantification of Multiple Classes 
of Phenolics in Fruits and Beverages Urska Vrhovsek, Domenico Masuero, Mattia 
Gasperotti, Pietro Franceschi, Lorenzo Caputi, Roberto Viola, Fulvio Mattivi Journal 
of Agricultural and Food Chemistry 2012 60 (36), 8831-8840 
 
*Reprinted with permission from the Journal of Agricultural and Food Chemistry.  
Copyright © 2012 American Chemical Society 
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Along with the widespread interest in phenolic compounds as food 
constituents, numerous separation and detection methods for their identification and 
quantification in different matrices have been developed in recent years (28*). 
However, the number of compounds that have been quantified in a single run 
with existing methodologies is still relatively modest when compared to the potential 
coverage of metabolites that could be achieved using the powerful technologies 
available on the market for chromatography and mass spectrometry, which are 
widely used in other fields, such as multi-residue pesticide analysis in food (29) and 
hormones (30). Targeted metabolomics represents an attractive strategy for food 
analysis. This methodology aims to quantify a predefined set of metabolites, typically 
dozens or hundreds of known compounds, based on metabolite-specific signals (33, 
34).  
In particular, in targeted metabolomics approaches, using triple-quadrupole 
mass spectrometers, a precursor ion and a fragment of the precursor ion, producing a 
molecular weight and structure-specific measurement for a single metabolite, are 
used for the sensitive and accurate determination of the compound concentration 
over a wide dynamic range. Simultaneous analysis of multiple transitions results in 
multiple reaction monitoring (MRM). 
The aim of this study was to develop a rapid and versatile targeted 
metabolomics method for the quantification of multiple classes of phenolics that 
could be used for high-throughput analysis of fruits and beverages.  
A detailed introduction, description of the methods and discussion of the 
results are attached in the original publication. 
 
An UPLC-MS/MS metabolite profiling method for food analysis, allowing 
rapid exploration of the presence of polyphenols in different food matrices, with 
                                                 
*
 References are reported in the same order and listed in the attached publication 
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converging opportunities for research applications in plant science and human 
nutrition was developed.  The high sensitivity of MRM-based mass spectrometry 
and the wide dynamic range of triple-quadrupole spectrometers provide valuable 
insight for the analysis of complex matrices such as fruit, and more in general food, in 
which analyte concentrations span several orders of magnitude.  
The method developed for the profiling of phenolic compounds is versatile 
and could be successfully applied to the analysis of a range of different matrices, not 
limited to those chosen for validation. The short duration of the analysis and 
straightforward sample preparation make the methodology suitable for high-
throughput varietal screening studies and for use in assisting plant breeders to select 
specific chemotypes. 
 
 My personal contribution to this work mainly concerned the setting up of 
instrumental conditions, strategies for the execution of future routine analysis and 
validation processes. After automatic detection of the best transition for each 
compound in the method and separation during the chromatographic run, I was 
personally involved in optimising the parameters to construct the method, hence in 
the selection of the quantifier ion, qualifier ion, and their specific ratio (according to 
European pesticide guidelines (40)), all these results being gathered together in Table 
1. This table represents the core of the method, giving a list of all the transitions, 
energies involved in the fragmentation and ratios, along with the retention times of 
all the 135 phenolic compounds in a total run of 11 minutes. Moreover, I was 
involved in the preparation of the standard solution for calibration, the rational 
design of the dilution and mixing of different compounds, processing of the curves 
with subsequent validation of the methods in terms of linearity and limits of 
quantification (Figures 1 and 2, Supplementary Table S2). Finally, I was involved in 
sample preparation and analysis of the preliminary samples for the initial application 
of the method adopting different fruits and beverages using UPLC-MS/MS. The 
quantitative results of this application are graphically presented in Figure 6 with all 
the compounds identified in the matrices.   
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Food Chemistry 
Chapter 1.2 
 
 
 
Ellagitannins in strawberries: Their isolation, 
structural elucidation and profiling during fruit ripening  
 
 
 
 
 
 
 
This chapter has been reprinted* from:  
 
1. Clarifying the Identity of the Main Ellagitannin in the Fruit of the Strawberry, Fragaria 
vesca and Fragaria ananassa Duch. Urska Vrhovsek, Graziano Guella, Mattia 
Gasperotti, Elisa Pojer, Mirella Zancato, Fulvio Mattivi, Journal of Agricultural and 
Food Chemistry, 2012, 60, 10, 2507-2516 
 
2. Evolution of Ellagitannin Content and Profile during Fruit Ripening in Fragaria spp. 
Mattia Gasperotti, Domenico Masuero, Graziano Guella, Luisa Palmieri, Paolo 
Martinatti, Elisa Pojer, Fulvio Mattivi, Urska Vrhovsek Journal of Agricultural and Food 
Chemistry 2013 61 (36), 8597-8607 
 
*Reprinted with permission from the Journal of Agricultural and Food Chemistry.  
Copyright © 2013 American Chemical Society 
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Ellagitannins are a complex family of hydrolysable tannins which have been 
found only in dicotyledoneous angiosperms (1†). Ellagitannins are present in the 
human diet, being contained in berries and strawberries in large amounts (2).  
This class of natural polyphenols has recently received considerable attention 
in the light of experimental evidence regarding purported anticancer properties (3, 4), 
antiproliferative properties (5, 6), antibacterial activity in relation to intestinal 
pathogens (7), and very recently anti-inflammatory activity at gastric level (8).  
There is little knowledge about the native forms of ellagitannins in 
strawberries and their biosynthetic behaviour during ripening (14-19). Their 
structural complexity is a major limiting step that prevents their study at molecular 
level. Due to the considerable diversity of ellagitannins, they still represent a 
challenge to food science and are a source of discussion in relation to their correct 
identification. Correct identification of the structure is clearly a prerequisite for 
understanding their bioavailability, bioactivity and metabolism.  
The structural elucidation of ellagitannins is a difficult task, because they are 
made up of the same building blocks (including but not limited to glucose, ellagic 
and gallic acid, and hexahydroxydiphenoyl (HHDP) units. As a consequence, many 
structurally related ellagitannins display characteristic, but very similar or sometimes 
almost identical, mass spectra. This issue, together with the lack of commercially 
available standards, makes their accurate identification and quantification very 
demanding. In the case of strawberries, there is fundamental disagreement about the 
identification of the main ellagitannin in the fruit. 
Due to the sheer complexity, the qualitative and quantitative composition of 
this class in strawberries has not yet been thoroughly resolved to date (14). This 
represents one of the major limitations in the study of health benefits and the human 
metabolism at molecular level. In order to assign the correct health properties to these 
compounds it is important to have specific knowledge about the chemical structure of 
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the native form of ellagitannins, their concentration, and the ellagitannin profiles 
present in fruits at different ripening stages and not only in ripe fruit.  
 
In this context, the aim of these two publications was primarily elucidation 
and profiling of the main ellagitannins. In the first publication, identification of the 
most abundant ellagitannin, after isolation, MS and NMR analysis, was clearly 
defined. The scope was to solve a major open question, namely whether the main 
ellagitannin in the strawberry is agrimoniin or sanguiin H-6, two isomeric forms of 
dimeric ellagitannins 
In the second publication, the scope was instead to isolate other ellagitannins 
and ellagic acid conjugates and their characterisation for a precise quantification. 
Moreover, with the use of high definition MS an exhaustive profile of all major 
ellagitannins was one of  the aims of the study, also in order to explain the behaviour 
of this class of compounds during fruit ripening in different Fragaria spp. It is 
important to answer this question due to several areas of scientific interest. From the 
point of view of plant biochemistry it is important to understand the fate of these 
compounds throughout ripening of the fruit, while on the other hand producers and 
consumers are concerned about the healthy properties of food. They are interested in 
learning how these compounds change while the fruit is edible, and the variability of 
the different genotypes.  
A detailed introduction, descriptions of the methods and discussion of the 
results are attached for both publications. 
 
The first important result was the unequivocal identification of agrimoniin as 
the most abundant ellagitannin in strawberries. After many years of uncertainty this 
was the first time that agrimoniin has been isolated and its structure characterised in 
the fruit of F. vesca and its presence reported as the main ellagitannin in both F. vesca 
and F. ananassa D. fruit.  
In the second publication the isolation and structural elucidation of other 
ellagitannins were reported, i.e. casuarictin and one ellagic acid conjugate, namely 
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methyl ellagic rhamnoside. Furthermore, MS profiling of 26 ellagitannins was 
performed in different Fragaria genotypes. Major qualitative and quantitative 
differences in the amount and profile of ellagitannins and ellagic acid conjugates 
were observed, both due to the variety and ripening stage.  
The results of this study show that genotype is a major factor in defining 
ellagitannin concentration and pattern in strawberries. The concentration of 
ellagitannins drops during ripening in all varieties. 
Both studies show that of fruit containing ellagitannins, strawberries represent 
the most important source of this class of compounds in the human diet, with 
agrimoniin probably being the most important ellagitannin consumed.  
 
My involvement in the first publication concerned the isolation of agrimoniin 
from Fragaria Vesca with the use of preparatory HPLC (see Figure 2) and UV and high 
definition analysis, the results being reported in Figure 6 and Figure 8. I also 
performed accurate quantification of agrimoniin with HPLC-DAD in different 
Fragaria spp. In the second publication I was again involved in isolation (Figure 1), UV 
analysis (Table S6) and MS characterisation. However the most challenging part of the 
research in which I was involved was high definition MS profiling of the 26 
ellagitannins identified, based on their spectra in each Fragaria spp. considered (the 
results are reported not only in the text but also in Figure 2, Table 1 and Table S5). 
After profiling and assignment of putative identification, I also performed 
quantification of the compound detected with a HPLC-DAD system, using the 
appropriate isolated ellagitannins (Table 2). A summary of the quantitative results for 
each cultivar and the woodland strawberry types are shown graphically in Figure 4, 
highlighting the drop in ellagitannins during fruit maturation. Moreover, as the first 
author I was responsible for writing the manuscript and managing the comments and 
improvements to the text of other co-authors.  
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Food chemistry 
Chapter 1.3 
 
 
 
 Polyphenols in a bowl of strawberries: 
Comprehensive profiling for better correlation with 
nutritionally significant properties 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter will shortly be submitted for publication as a manuscript:  
 
Overall dietary polyphenol intake in a bowl of strawberries: the influence of Fragaria spp. in 
nutritional studies Mattia Gasperotti, Domenico Masuero, Fulvio Mattivi, Urska 
Vrhovsek 
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In Europe, average strawberry consumption is 2.16 kg/year per person, 
including raw and processed fruit (2‡). On this basis, strawberries would clearly 
appear to be one of the most widely consumed berries. Furthermore strawberries are 
one of the most important sources of polyphenols in the human diet, being a rich 
source of these healthy phytochemical compounds (3,4). 
The regular consumption of strawberries in the diet contributes significantly to 
the intake of different phenolic compounds. Several classes of polyphenols are 
present in a bowl of strawberries (5,6). Studies of different cultivars including 
profiling of polyphenols have already been performed in some cases, but without 
quantitative determination or detailed characterisation (7-11). The most abundant 
classes of polyphenols in the strawberry are proanthocyanidins and anthocyanins, 
followed by ellagitannins and flavonol glycosides (3,4,14). 
Comprehensive quantification of polyphenols in food matrices is an essential 
step in assessing their biological mechanisms, nutritional properties and healthy 
effects. However due to the huge variety of polyphenol compounds, their precise 
characterisation in fruit or vegetables, even the most widely consumed, is still 
unclear. To study the nutritional quality of any fruit it is essential to start from 
phytochemical profiling of the native compounds in fruits and then move on to more 
complex bioavailability studies with in vivo trials. 
Thus the aim of this study was to present a comprehensive picture of 
strawberry polyphenols, reflecting their intake in the human diet. To date a detailed 
overview has been lacking in the literature or the databases available.  
A detailed introduction, description of the methods and discussion of the 
results have been included in the manuscript ready for the submission. 
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A total of 56 individual compounds were accurately identified and quantified 
with a triple-quadrupole mass spectrometer, their concentration ranging from 1 
ug/100 g for low abundant polyphenols to 40 mg/100 g of fresh fruit. Furthermore, a 
spectrophotometric assay was carried out for precise estimation of high-molecular 
mass proanthocyanidins (HMWP).  
Quantitative data at molecular level are provided for all 56 compounds and 
indirect quantification was applied to the complex family of HMWPs. Several 
compounds were identified and quantified for the first time. In Fragaria Vesca, 
taxifolin, which is one of the most concentrated polyphenols after anthocyanins and 
ellagitannins, was quantified in the strawberry for the the first time. This study 
represents the most comprehensive targeted profiling of strawberry polyphenols, in 
terms of the number of individual compounds identified and quantified.  
 
My personal involvement in this manuscript regarded evaluation of the gap in 
knowledge relating to the precise composition of strawberry polyphenols in the 
literature. I performed quantitative analysis by applying the targeted method 
developed in Chapter 1.1 and I developed a new rapid UPLC-MS/MS method for 
anthocyanins and ellagitannins (see Table 1, Figure 1), with the isolated ellagitannins 
presented in Chapter 1.2. I produced a list of compounds with their precise 
quantifications in different Fragaria spp. (Table 2 and Figure 2). Moreover, I performed 
the spectrophotometric assay and explorative analysis for the analysis of 
proanthocyanidins, using high definition MS (Figure 3). Furthermore, as the first 
author I was responsible for writing the manuscript and managing the comments and 
improvements to the text by other co-authors. 
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Abstract 
 
Strawberry (Fragaria x Ananassa Duch) represents one of the most important 
crops worldwide. Moreover strawberries are one of the most important sources of 
polyphenols in the human diet, being a rich source of these healthy phytochemical 
compounds.  
Strawberries are now considered to be a functional food, as demonstrated by 
evidence regarding their antioxidant, anti-inflammatory, antihypertensive and 
antiproliferative properties. However which kinds of compounds are involved is not 
fully understood at the moment.  
The aim of this study was to present a comprehensive picture of the amount of 
polyphenols present in the human diet. Attention was focused on the consumption of 
a standard bowl of different Fragaria spp. An already published method for the 
quantification of multiple classes of phenols and the development of a method for the 
simultaneous quantification of anthocyanins and ellagitannins was used for this 
purpose. Furthermore, spectrophotometric assay for precise estimation of high-
molecular mass proanthocyanidins was applied.  
A total of 56 individual compounds were accurately identified and quantified 
with a triple-quadrupole mass spectrometer their concentration was ranging from 1 
ug/100 g, for low abundant polyphenols, to 40 mg/100 g of fresh fruit. Several 
compounds were identified or quantified for the first time in strawberry fruits. 
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Introduction 
 
According to the statistical database of the Food and Agriculture Organization 
of the United Nations (FAO) (1), the strawberry (Fragaria x Ananassa Duch) represents 
one of the most important crops worldwide, with worldwide production and overall 
global trading of 4.1 million tons. In terms of production, there was a global increase 
of 20% from 2005 to 2011, with an increase of 50% in Europe and the United States 
alone.  
In the European market, average strawberry consumption is 2.16 kg/year per person, 
including raw fruit and processed food (2). On the basis of this figure, strawberries 
would clearly appear to be one of the most widely consumed berries. Furthermore 
strawberries are one of the most important sources of polyphenols in the human diet, 
being a rich source of these healthy phytochemical compounds (3, 4).  
Regular consumption of strawberries in the diet contributes significantly to the 
intake of different phenolic compounds. Several classes of polyphenols are present in 
a bowl of strawberries (5, 6). Studies of different cultivars including profiling of 
polyphenols have already been performed in some cases, but without quantitative 
determination or without detailed characterisation (7–11). Furthermore the chemical 
composition varies with the genotype, as already reported, but also depending on 
agricultural practices, the degree of maturity and environmental factors (12,13). The 
most abundant polyphenols are proanthocyanidins and anthocyanins, followed by 
ellagitannins and flavonol glycosides (3,4, 14). Analysis of proanthocyanidins and 
ellagitannins, polymeric and oligomeric compounds, has so far been little studied, 
due to analytical problems and the complexity of their chemical characterisation. 
Only recently has been published a complete profile for ellagitannins, with 
identification and precise quantification of several molecules (15), while similarly 
detailed information is still not present in the literature in relation to 
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proanthocyanidins, although this class of compounds represents the main group of 
polyphenols in the strawberry (16). 
Strawberries are now considered to be a functional food, with multiple health 
benefits over and beyond nutritional needs, as demonstrated by extensive evidence 
regarding their antioxidant, anti-inflammatory, antihypertensive and antiproliferative 
properties (17). Epidemiological studies have been shown an inverse correlation 
between the consumption of fruits rich in polyphenols and degenerative or 
proliferative disease, cardiovascular disease and chronic diseases (3, 17–19). The 
potential effects of the consumption of strawberries on health have been well 
described in the literature for decades, but the precise mechanism of polyphenols’ 
healthy effect on the mammalian system are still generally unclear. Even which kinds 
of compounds are involved is not fully understood at the moment.  
Comprehensive quantification of polyphenols in food matrices is an essential 
step in assessing their biological mechanism, nutritional properties and healthy 
effects. However due to the huge variety of polyphenol compounds, their precise 
characterisation in fruit and vegetables, even the most widely consumed, is still 
unclear. To study the nutritional quality of any fruit it is essential to start with 
phytochemical profiling of the native compounds and then move on to more 
sophisticated bioavailability studies. Moreover, in bioavailability studies today the 
role of gut microflora also has to be taken into account and can improve the 
variability of the phytochemical compounds present in the consumed fruits (20, 21). 
The aim of this study was to present a comprehensive picture of the quantity 
of polyphenols present in the human diet. Attention was focused on the consumption 
of a standard bowl of different Fragaria spp. (100 g). Indeed, to assist long and 
expensive future nutritional studies on the effective healthy effects of the strawberry, 
it is necessary to carry out detailed profiling of its polyphenolic composition. Thus an 
already published method for the quantification of multiple classes of phenols and 
the development of a method for the simultaneous quantification of anthocyanins 
and ellagitannins was used for this purpose. Furthermore, spectrophotometric assay 
for precise estimation of high-molecular mass proanthocyanidins (HMWP) was used. 
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A total of 56 individual compounds were accurately identified and quantified with a 
triple-quadrupole mass spectrometer, ranging from 1 ug/100 g, for low abundant 
polyphenols, to 40 mg/100 g of fresh fruit. 
To our knowledge this is the first time that such a comprehensive targeted 
profile has been performed on strawberry polyphenols, in terms of the number of 
individual compounds identified and quantified at the same time with proper 
standard references.  
 
 
Materials and Methods 
 
 Chemicals and Reagents. All the chromatographic solvents were HPLC grade 
or LC-MS grade for the MS experiments. Acetonitrile, acetone, methanol and formic 
acid were purchased from Sigma Aldrich (Milan, Italy). Detailed information 
regarding the standard references used and vendors are reported in Vrhovsek et al. 
(22) Sanguiin H6 was isolated as described in Gasperotti et al. (23), agrimoniin as 
described in Vrhovsek et al. (24), casuarictin and methyl ellagic acid rhamnoside as 
described in Gasperotti et al. (15). 
 
 Plant Material. Different Fragaria spp. 6 Fragaria x ananassa cultivars (Alba, 
Clery, Eva, Elsanta, Darselect, and Portola) and 2 accessions (one red and one white) 
of Fragaria vesca were used. The plants were grown in the same experimental field in 
Vigalzano (Trentino, Italy; 520 AMSL) during the 2011 season. All the cultivars were 
grown in standardised conditions in order to minimise the effect of environmental 
and agronomic factors. For each Fragaria spp. analysed, 3 repeats of 6 plants (18 
plants in total) were considered, in order to obtain 3 biological replicates. The plants 
were cultivated with the soilless technique. Plants of the same cultivar were obtained 
vegetatively. For each cultivar, 250 g of strawberries were harvested at commercial 
ripeness. Detailed information regarding the agronomical conditions is reported in 
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Gasperotti et al. (15). The strawberries were harvested at commercial ripeness. Once 
collected the samples were stored in a freezer at -20 ° C until extraction. 
 
 Extraction of Phenolic Compounds. Extraction was performed as reported in 
Mattivi et al. (25) with an acetone/water mixture (70/30 v/v), avoiding the addition 
of acids in order to prevent any possible chemical hydrolysis. Briefly, 60 g of fresh 
fruit was homogenised in a 847-86 model Osterizer blender at speed one, in 2 x 100 
mL of mixture acetone/water (70/30 v/v) for 1 min and made up to 250 ml with the 
same solvent.  The centrifuged extracts were stored at –20 °C until analysis. 
 
 Sample Preparation for UPLC-MS/MS Analysis. An aliquot of the extract, 1.5 
ml, was completely dried under a stream of nitrogen. Then, 150 µL of 
methanol/water (50:50), with 1mg/L of rosmarinic acid as internal standard, was 
added to the dry sample and filtered (0.45 µm) into an HPLC vial. The samples, 10 
times concentrated, were now ready for further UPLC-MS/MS analysis. The internal 
standard was added to monitor the analytical performance of the instrument. 
 
 UPLC-MS/MS Method for Anthocyanins and the Main Ellagitannins. An 
UPLC-MS/MS method was developed by combining anthocyanins, reported in the 
literature (26), and the main ellagitannins detected (15) in the strawberry. The 
analysis was performed with an ultra performance LC (UPLC) system coupled with a 
triple quadrupole (TQ) mass spectrometer. The UPLC system used was a Waters 
Acquity UPLC system (Milford, Massachusetts, USA). Separation was performed 
with a Waters Acquity UPLC column (Milford, Massachusetts, USA), BEH C18 (150 
mm x 2.1 mm, 1.7 µm) equipped with the proper guard column, maintained at 60°C. 
The injection volume was 2 µL and solvent flow was 0.45 mL/min. Mobile phases of 
2.5% formic acid in Milli-Q water (A) and acid in acetonitrile (B) were used. 
Chromatographic separation was performed using a gradient as follows: 0 min, 5% B; 
0-10 min, 5%-25% B; 10-10.5 min; 25-90% B; 10.5-12.50 min, 90% B, 12.60-16.60 min, 
5% as equilibration time. The TQ mass spectrometer used was a Waters Xevo TQ 
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(Milford, Massachusetts, USA) coupled with an electrospray interface. Direct 
injections of each individual compound were used to optimise the MRM conditions. 
This was done automatically by the Waters IntelliStart software, and then manually 
checked for selection of the quantifier and qualifier ions. The MRMs for each 
compound are listed in Table 1 with cone voltages and collision energies. Calibration 
curves were performed for each individual compound for precise quantification, 
using commercially available anthocyanins and the previously isolated 
ellagitannins.(15, 23, 24) Calibration curves were prepared ranging from 0.0005 mg/L 
to 20 mg/L. 
 
 UPLC-MS/MS Method for Multiple Classes of Phenolics. Quantitative 
analysis for the rest of the polyphenols, excluding anthocyanins and ellagitannins, 
was carried out with a previously validated method for the rapid quantification of 
multiple classes of phenolics (22). Briefly, the analysis was performed with the same 
ultra performance LC (UPLC) system, coupled with the triple quadrupole (TQ) mass 
spectrometer used in the previous method. Separation was performed with a Waters 
Acquity UPLC column (Milford, Massachusetts, USA), HSS T3 (100 mm x 2.1 mm, 1.8 
µm) equipped with the proper guard column, maintained at 40°C. The injection 
volume was 2 µL, with a flow of 0.4 mL/min. Mobile phases of 0.1% formic acid in 
Milli-Q water (A) and 0.1% formic acid in acetonitrile (B) were used. 
Chromatographic separation was performed using a gradient as follows: 0 min, 5% B; 
0-3 min, 5%-20% B; 3-4.30 min; 20% B; 4.30-9 min, 20%-45% B, 9-11 min, 45%-100% B, 
11-14 min, 100%; and 14.01-17 min, 5% as equilibration time (22). Further information 
regarding the UPLC-MS/MS method and MRM quantification are described in 
Vrhovsek et al. (22). A total of 44 polyphenols were identified among the samples and 
proper calibration curves were obtained for each individual compound for precise 
quantification. Calibration curves were prepared, with appropriate standard 
references, ranging from 0.0005 mg/L to 20 mg/L. 
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 Analysis of Proanthocyanidins. The assay to determine the quantity of 
proanthocyanidins was based on their transformation into anthocyanidins, in a 
warm, acid environment (27). An aliquot of the initial extract, 5 mL, was evaporated 
using a rotavapor in order to eliminate the acetone fraction and dissolved in a 5 mL 
flask with 0.05 M H2SO4. One mL of this solution was loaded onto a conditioned Sep-
Pak C18 (Waters, Milford, MA, USA), which was previously washed with 2 mL of 5 
mM H2SO4. Proanthocyanidins were eluted with 3 mL of MeOH and collected in a 50 
mL flask, shielded from light with aluminium foil, containing 9.5 mL absolute EtOH. 
12.5 mL of FeSO4 was added to the mixture in concentrated HCl (300 mg/L) and then 
immediately placed in a boiling water bath and refluxed for 50 min. After 10 min, the 
spectrum from 380 to 700 nm was recorded in a 10 mm cell, against a blank (water). 
The tangent from the minimum (450 nm) was drawn, and the absorbance between the 
maximum (550 nm) and the tangent was measured. To subtract natural anthocyanins 
present in the sample, which can interfere with the assay, one mL of the latter 
solution dissolved in 0.05 M H2SO4 was prepared in the same conditions. However, 
in this case the reaction was carried out in an ice bath and the absorbance obtained 
was then subtracted to obtain the net absorbance value. The proanthocyanidins 
concentration (mg/L) can be conventionally expressed as the cyanidin formed. 
Further information is present in the literature (27–29). 
  
 Explorative Profiling of Proanthocyanidins. An aliquot of the acetone extract 
was concentrated 4 times and dissolved in methanol/water (50:50) for explorative 
analysis using high definition mass spectrometry (HDMS), a Synapt Waters, coupled 
with UPLC and injected with a previously 60 min. chromatographic method(23). The 
molecular ions of the main oligomeric form were selected and extracted from the 
HDMS spectrum. 
 
 Data Analysis and Statistical Analysis. Data processing was carried out using 
Waters MassLynx 4.1 and TargetLynx software. All samples were in biological 
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triplicates. The data collected were presented as average values and standard 
deviations. 
 
 
Results and Discussion  
 
 Variety. The varieties chosen for the dietary intake of polyphenols included 2 
wild accessions of Fragaria Vesca, the red and white types, whereas the 6 main 
representative cultivars of Fragaria x Ananassa were chosen: Portola, Eva, Elsanta, 
Clery, Darselect and Alba. The chosen cultivars were selected from those most widely 
consumed in both Italy and Europe. All the samples were grown and picked in 
Trentino, Italy in the same agronomical conditions and harvested at commercial 
maturity to avoid any environmental and agronomical effects on the polyphenolic 
composition (30). Due to the difference in the varieties, cultivars and accessions 
investigated, it was expected that the amount of polyphenols would make it possible 
to obtain a clear estimate of the intake of strawberry polyphenols in both Italy and 
Europe associated with the consumption of a bowl of strawberries, 100 g, of the most 
widely used cultivars or wild species. 
 
 Targeted Profiling of Strawberry Polyphenols. The polyphenols in the fruit of 
the different Fragaria spp. considered were identified and quantified precisely with 
the use of a TQ mass spectrometer. With the use of the triple quadrupole mass 
spectrometer several compounds were found in traces, leading to quantification of 
some polyphenols never previously reported in the strawberry. Each compound was 
identified and confirmed in the samples by checking whether both transitions 
(MRMs), qualifier and quantifier ions prepared for the method of quantification with 
the appropriate standard references, were present in the chromatograms. With the 
use of the two complementary UPLC-MS/MS methods (Figure 1), a total of 56 
compounds were separated, identified and quantified with standard references in the 
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samples. The list of all the compounds identified is presented in Table 1, together 
with the amount recovered for each sample. The values are reported in ug/100 g, as 
the average value of the 3 replicates (and their standard deviation). The amounts 
found ranged from a few ug/100 g to many mg/100 g of fresh fruit. 
As the main outcome, a list of polyphenols was produced for the creation of 
databases reporting on polyphenol composition in fruit and vegetables (5, 6) 
providing more information also as compared to similar studies involving targeted 
profiling of strawberry polyphenols (7, 8, 10, 14, 31, 32). Moreover, in comparison to 
untargeted profiling studies on the strawberry (8, 11, 33) a similar number of 
polyphenolic compounds was reported but with a major improvement in 
identification/quantification and not only with tentative identification on the basis of 
fragmentation patterns. The total amounts and the relative percentages of the main 
classes or groups of classes are shown graphically in Figure 2. In order to simplify the 
pie charts, 5 groups were highlighted: proanthocyanidins (HMWP), ellagitannins, 
anthocyanins, flavonoids (adding together flavones, flavanones, flavan-3-ols and 
flavonols) and other polyphenols (adding together benzoic acid derivatives, 
phenylpropanoids, stilbenes, phenol glycosides and dihydrochalcones). From the pie 
charts it is clear that proanthocyanidins are the most abundant polyphenols in the 
strawberry (16). The other two main groups are anthocyanins and ellagitannins, 
followed by flavonoids and traces of other polyphenols. Considering the total 
amounts in the strawberry, the highest values were found for the two accessions of 
Fragaria Vesca, 324 and 448 mg/100 g respectively for the red and white types. The 
amounts in the cultivars were lower, falling between 204 and 288 mg/100 g 
respectively for the Clery cv and the Darselect cv. The data on total polyphenol 
content are in accordance with the average values calculated in a different manner, 
i.e. Follin assay for total polyphenol content, and present in databases, but of course 
with more detailed characterisation of the individual amounts (5, 6). 
 
 Classes of Polyphenols. Using 3 rapid methods, 2 instrumental and one 
spectrophotometric assay, it was possible to identify the main classes of polyphenols 
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present in the strawberry, but it was also possible to detect many minor polyphenols 
present in traces. A total of 56 polyphenols are listed in Table 1, all identified and 
quantified with the proper standard references, with the exclusion of 
proanthocyanidins. In this way it was possible to build up a comprehensive picture of 
the presence and type of different classes of polyphenols in a bowl of strawberries, 
along with the quantity of proanthocyanidins, not described in detail at molecular 
level, that may be consumed in the human diet.  
 Proanthocyanidins. Precise quantification and characterisation of these is still an 
open problem in terms of polyphenol analysis, due to their complexity, given that 
they are compounds with a high molecular weight. A number of strategies have been 
reported for the study of high molecular weight proanthocyanidins (HMWPs), 
including the use spectrophotometric assay (28), normal phase separation coupled 
with fluorescent detector (34), phloroglucinol adducts or the thiolysis method (35). 
Interestingly, in terms of estimation, good correlation with the accepted Bate-Smith 
assay was shown as compared to more laborious instrumental methods (i.e 
phloroglucinol adducts or thiolysis) (29). For this reason Bate-Smith assay was used 
for the analysis of HMWPs, given that other more precise methods are not reliable for 
their characterisation and quantification. However, as an exploratory example, the 
HDMS spectrum of a sample of the red type Fragaria Vesca showed extracted ions of 
the main tentative proanthocyanidins reported in the strawberry (16) (Figure 3). 
HDMS analysis confirmed the presence of some peaks at m/z 577 (dimers), 865 
(trimers), 1153 (tetramers) and 720 (bicharged pentamers) corresponding to 
(epi)catechin-based proanthocyanidins. 
 Representing the most abundant polyphenols in the strawberry (Figure 2), the 
amount consumed in a bowl of strawberries is between 135 mg/100 g and 205 
mg/100 g respectively for the Clery cv and the Darselect cv, while the amount is 
higher in the red type of wild strawberry, namely 270 mg/100 g. As a major class of 
strawberry polyphenols, they represent between 54.8% and the 77.4% of polyphenolic 
compounds. The cultivar with the highest relative value is the Portola cv. 
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 Anthocyanins. The red colour of strawberries comes from the presence of 
anthocyanins. In strawberries, anthocyanins are made up of a mixture of cyanidin, 
pelargonidin and peonidin glycisides, mainly glucosides, galactosides and 
rutinosides (26). On the contrary, anthocyanins are not present in the white type of 
Fragaria Vesca, with the exception of some traces of cyanidin glucoside and 
galactoside, and as a consequence the fruit is white/green. The main anthocyanin in 
the red strawberry is pelargonidin-3-glucoside (26, 36) (up to 43 mg/100 g in the 
Darselect cv), followed by cyanidin-3-glucoside (up to 12 mg/100 g in the red type of 
Fragaria Vesca and up to 0.4 mg/100 g in the cultivars) and cyanidin-3-galctoside. 
Cyanidin-3-rutinoside, pelargonidin-3-rutinoside and peonidin-3-galactoside were 
also found in the cultivars, while they were not present at all in Fragaria Vesca. 
A certain variability in terms of the compounds identified and the amounts can 
be observed in the cultivars. The Elsanta cv had the lowest number of different 
anthocyanins, although the total amount recovered was nearly 35 mg/100 g, while 
the Portola cv, with the largest number of different anthocyanins, was the cultivar 
with the lowest total amount, 24 mg/100 g. 
 Ellagitannins. In the strawberry ellagitannins are the third most concentrated 
class of polyphenols, the main ellagitannins having recently been isolated for their 
clear identification and precise quantification (15, 24). From previous publications, 
only the 3 main ellagitannins – agrimoniin, casuarictin and sanguiin H-6 – and ellagic 
acid with the methyl ellagic acid rhamnoside, isolated and characterised using NMR 
(15, 23, 24), were considered for the purpose of having a picture of the overall intake 
of polyphenols present in a bowl of strawberries. More in-depth profiling with many 
other ellagitannins has already been proposed for the same cultivars (15). 
 As already shown, agrimoniin was the main ellagitannin in the strawberry 
(from 84 to 9 mg/100 g), followed by casuarictin (from 19 to 5 mg/100 g) and then 
sanguiin H-6 (from 2.2 to 0.2 mg/100 g. The concentration of ellagic acid was from 7 
to 0.3 mg/100 g. 
 Methyl ellagic acid rhamnoside was present in large amounts in Fragaria Vesca, 
with a concentration of 28 and 35 mg/100 g respectively for the white and red types. 
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Interestingly, traces of these ellagic conjugates were also found in the cultivars (11-2.8 
ug/100 g) while in previous publications they were not reported (15). 
 Flavonoids. The fourth most characteristic group of polyphenols (see Figure 2) 
in the strawberry is the flavonoid family (without considering the anthocyanins 
described above as an independent class of polyphenols). The flavonoids found in 
strawberry were flavones, flavanones (naringenin alone), flavan-3-ols and flavonols 
and dihydroflavonols. 
In the literature considered for this publication, no information regarding the 
survey of flavanones, naringenin or flavones, namely luteolin or hesperidin, was 
found. However, some traces of luteolin, luteolin-7-glucoside, hesperidin and 
naringenin were detected in the samples chosen. 
The main flavan-3-ol detected in the strawberry was catechin (5.9-1.8 mg/100 
g), while epicatechin was about 10 times lower in all the Fragaria spp. The dimers of 
the flavan-3-ols identified were instead procyanidin B1 and B3, in accordance with 
the literature.(8) In this case procyanidin B3 was about one grade of magnitude 
higher then procyanidin B1 (2.8-1 as compared to 0.58-0.17 mg/100 g). These flavan-
3-ols are not listed in the HMWP group, since they do not respond so well to the Bate-
Smith assay, being more selective for high molecules (29) and due to the fact that 
there are standard references available for quantification of these molecules. 
The content of overall flavonols, i.e. quercetin, unbound kaempferol and 
glycosides and isorhamnetin glycosides, varied in the samples from 0.9 mg/100 g 
(Portola) to 11 mg/100 g (F. Vesca, red type). Of the glycosides, quercetin-3-
glucuronide was the most abundant in all the cultivars and wild types, in accordance 
with the literature for the cultivars (10, 16) but not reported in relation to the wild 
types (37). Quercetin-3-glucuronide was followed by kaempferol-3-glucuronide, 
which was the second most abundant (from 0.28 to 0.66 mg/100 g) and kaempferol-3-
glucoside (from 0.09 to 0.26 mg/100 g) in the cultivars selected. In the wild type 
quercetin-3-glucuronide was followed by quercetin-3-glucoside and kaempferol-3-
glucoside, in accordance with the literature (37).  
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Interestingly, five different adducts made with rutinose are present in almost 
all the cultivars considered, but have never been reported in the literature (10, 16, 31, 
37, 38), with the exception of isorhamnetin rutinoside (11) and quercetin rutinoside 
(rutin) (7, 33), but with no information regarding their concentration. Another 
rutinoside adduct clearly found for the first time is kaempferol-3-rutinoside, not 
present in any of the articles considered. 
Likewise, the free forms of flavonols, i.e. quercetin and kaempferol, have never 
been reported in the literature, or in untargeted profiling studies of the strawberry 
(33), and some traces in the samples were detected. 
The dihydroflavonol family (added to flavonols in Table 2), i.e 
dihydroquercetin (taxifolin) and dihydrokaempferol in the Fragaria spp. considered, 
was present. Quantitative amounts are proposed for the first time in this publication, 
since their presence was only tentatively reported in an untargeted study (39). 
Remarkably, taxifolin appears to be the most abundant flavonoid, after anthocyanins, 
with a concentration of 9.5 and 8.5 mg/100 g respectively in the red and white types 
of wild strawberry. 
 Other Polyphenols. In this work it was possible to significantly increase the 
number of compounds detected with the use of a TQ mass spectrometer and also to 
characterise in detail many other polyphenols which are not as abundant as the 
previous polyphenols discussed above. These minor polyphenols were included in 
the category of other polyphenols (incorporating benzoic acid derivatives, 
phenylpropanoids, stilbenes, phenol glycosides and dihydrochalcones) in Figure 2 
and they represent less than 0.1 % of the total amount of polyphenols that may be 
consumed in a bowl of strawberries. The individual concentration was no more than 
100 ug/100 g in any of the samples. 
Compounds deriving from the benzoic acid, i.e. p-hydroxybenzoic acid, 
cinnamic acid, vanillin, vanillic acid, 2-6-dihydroxybenzoic acid methyl gallate or 
cathecol, were present together, with a concentration spanning from 30 ug/100 g to 
112 ug/100 g. They have already been identified as putative metabolites but with no 
information about their concentration (39). 
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Caffeic acid, ferulic acid, p-coumaric acid and chlorogenic acid – classified as 
phenylpropanoids – have already been reported in the literature but only confirmed 
with the photo diode array system (38), while chlorogenic acid was detected in 
untargeted data (11) as a putative metabolite with no information about 
concentration, although chlorogenic acid was the most abundant among the latter 
compounds (75 ug/100 g in cv. Elsanta). Traces of trans-coutaric acid were also found 
and have never been reported in previous studies. 
Some stilbenes were also detected, in particular trans-piceid and cis-piceid, 
which have never been detected in the strawberry, due to their extremely low 
concentrations. The total concentration of stilbenes was from 3.4 to 7 ug/100 g in the 
Portola cv and white type of F. Vesca respectively.  
Phloretin and phlorizin, belonging to the dihydrochalcones family, were 
reported for the first time by Hilt et al. (40), but no evidence was found in other 
publications. The presence of another dihydrochalcone, namely trilobatin, detected in 
traces in the samples considered, has also never been reported in the literature.  
 
 
Conclusion 
 
 This work offers some important new aspects and improvements in the study 
of strawberry polyphenols, which may also apply to the study of other polyphenols-
based food. The 56 polyphenols listed in this publication certainly do not represent a 
complete list of polyphenols present in the strawberry, but to our knowledge, at the 
moment they offer the most up-to-date list of clearly identified compounds, without 
any tentative identification, since they were compared with their reference 
compounds. Furthermore, quantitative data are provided for all the compounds and 
estimation only for the complex HMWP family. Several compounds were identified 
or quantified for the first time, not only because present in traces. Indeed, taxifolin 
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was quantified for the first time in Fragaria Vesca, representing one of the most 
concentrated polyphenols after anthocyanins and ellagitannins. 
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Figure 1 UPLC profile of the polyphenols detected in strawberry 
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Figure 2 Total amount of polyphenols and their percentage in Fragaria spp., 
grouped accordingly to Figure 1, with the addition of proanthocyanidins. 
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Figure 3 Preliminary High Definition MS analysis of proanthocyanidins. 
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Table 1 MRM Parameters of anthocyanins and ellagitannins 
 
     quantifier ion qualifier ion 
compound 
Rt 
min
. 
ES 
Cone 
Voltage 
(V) 
Q1 
m/z 
Collision 
Energy (V) 
Q2 
m/z 
Collision 
Energy (V) 
Q2 
m/z 
anthocyanins 
Cyanidin-3-galactoside 2.54 + 26 449.3 22 287.2 66 137.2 
Cyanidin-3-sambioside 2.81 + 30 581.3 26 287.2 72 137.2 
Cyanidin-3-glucoside 2.83 + 26 449.3 28 287.2 58 137.2 
Cyanidin-3-arabinoside 3.09 + 24 419.3 24 287.2 56 137.2 
Cyanidin-3-rutinoside 3.15 + 34 595.4 38 287.2 66 137.2 
Pelargonidin-3-glucoside 3.45 + 24 433.3 24 271.2 56 121.1 
Peonidin-3-galactoside 3.63 + 24 463.3 24 301.1 42 286.1 
Pelargonidin-3-rutinoside 3.94 + 30 579.2 20 433.1 30 271 
Peonidin-3-rutinoside 4.37 + 30 609.2 30 301.7 56 286.1 
ellagitannins 
Casuarictin 3.27 - 66 934.7 26 632.7 46 300.8 
Sanguiin H6 3.63 - 34 934.1 22 632.8 38 300.8 
Agrimoniin 5.06 - 32 934.1 22 632.8 46 300.8 
Methyl ellagic acid 
rhamnoside 6.97 - 30 460.8 18 314.8 20 299.8 
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Table 2 Quantitative results of all the polyphenols detected in Fragaria spp. Data are 
the average of the three replicates and their standard deviation in italics. 
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 Targeted profiling method for twenty-three 
metabolites related to polyphenol gut microbial 
metabolism in biological samples 
 
 
 
 
 
 
 
 
 
This chapter has been reprinted* from: 
 
Development of a targeted method for twenty-three metabolites related to polyphenol gut 
microbial metabolism in biological samples, using SPE and UHPLC-ESI-MS/MS Mattia 
Gasperotti, Domenico Masuero, Graziano Guella, Fulvio Mattivi, Urska Vrhovsek, 
Talanta, 2014 120, 221-230 
 
*Reprinted with permission from Talanta. 
Copyright © 2014 Elsevier 
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By identifying biologically active molecules and their mechanisms, interaction 
or dietary response in individuals, modern nutrition tries to understand how the 
biological system can be affected or influenced by dietary intervention.  
Polyphenol bioactivity has been correlated to bioavailability and catabolism, 
but their biological effects cannot be attributed only to the native forms, as found in 
food sources, but also and above all to their metabolites (4-7§). The factor most 
influencing their fate after consumption is the microbial polyphenol metabolism, 
made up of the gut microbiota, which represents all the microorganisms present in 
the gastrointestinal tract (8). The majority of those ingested polyphenol reach the 
colon without any degradation, after passing thorough the oral cavity or the stomach. 
The colonic microflora has been confirmed as the major responsible for the 
polyphenol metabolism, from the release of the aglycone flavonoids to the small 
phenolic acids. The microbial polyphenol metabolism follows a general pattern, in 
which this extremely diverse group of plant polyphenols is converted to a relatively 
small number of common metabolites. For this reason, the compounds that can reach 
cells, tissues or target organs are chemically and biologically different from the 
original dietary polyphenols (11). 
In nutritional metabolomics, targeted based metabolomics or targeted profiling 
is aimed at quantitative analysis of a predefined metabolite group associated with a 
predefined class of compounds or pathway (19). Several pathways related to the 
microbial catabolism of polyphenols have been reported in the literature (23-26). 
However, there is a need for rapid and sensitive analytical methods that can quantify 
such metabolites for a large number of samples, as in the case of clinical studies or 
long term dietary intervention, in different matrices, with rapid and sensitive 
targeted metabolomics analysis (19). 
For these reasons the aim of the this part of the project was the development of 
a sensitive targeted metabolomics method for analysis of 23 polyphenol microbial 
                                                 
§
 References are reported in the same order and listed in the attached accepted manuscript 
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metabolites, suitable for application to rat organs and biofluids, carefully considering 
all aspects of sample preparation for such complex matrices and the expected low 
amount to be detected, in relation to the consumption of fruit rich in polyphenols. 
This part of the work was developed in order to analytically support in vivo 
experiments using a physiologically relevant dose of polyphenol microbial 
metabolites (reflecting the consumption of a putative dose of strawberries) or to 
eventually be translated to human studies.  
A detailed introduction, description of methods and discussion of the results 
are attached in the manuscript ready for the submission. 
 
A high-throughput, sensitive and reproducible method for targeted 
metabolomics for quantitative analysis of 23 polyphenol metabolites in six different 
biological matrices was developed. The development of a purification procedure 
made it possible to obtain cleaner samples and more concentrated samples, with low 
LOQs. By analysing different biological samples, such as blood, urine, liver, kidney, 
heart and brain spiked with target metabolites, it was possible to test metabolite 
detection in the matrix and validate the overall recovery of the method, from 
purification to quantification. 
 Considering the variety of matrices which can be treated in the same 
conditions with a single general quantitative analytical protocol for targeted based 
metabolomics, this method can be considered a general method for the simultaneous 
analysis of several chemically different compounds in a complex matrix. 
Consequently, this method can be used for nutritional studies and in particular 
with the expected amounts of polyphenol metabolites reported by Manach et al. (4), 
in which the expected total plasma concentration of polyphenol metabolites ranges 
from 0-4 µmol/L, with an intake of 50 mg of polyphenol aglycone equivalent.  
 
My personal involvement in this research started with the experimental design 
for the method development and selection of the metabolites included in the study. 
Moreover, I carried out the synthesis of two of the metabolites, urolithin A and 
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urolithin B, which are not commercially available. Along with the synthesis, I also 
carried out purification of the raw products of the synthesis, their precipitation and 
initial characterisation using MS. Precise identification and purity were then assigned 
using NMR, kindly performed by Prof. Graziano Guella. As regards method 
development, I personally performed all the experiments, protocols and validation 
presented in the manuscript. As first author I was responsible for writing the 
manuscript and managing the comments and improvements to the text by the other 
co-authors. 
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 Supplementary Fig. 1. 
Matrix-match calibration and solvent calibration curves and graphic displays 
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 Fate of microbial metabolites of dietary 
polyphenols in rats: Is the brain their target destination? 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter will be submitted shortly for publication as a manuscript:  
 
Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target 
destination? Mattia Gasperotti, Sabina Passamonti, Federica Tramer, Domenico 
Masuero, Graziano Guella, Fulvio Mattivi, Urska Vrhovsek. 
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 As already explained, the colonic microbiota produces a relatively small 
number of polyphenol microbial metabolites (PMMs) from a large number of 
different dietary polyphenols. These metabolites, being more absorbable than their 
polyphenolic precursors, are regarded as responsible for the healthy effects associated 
with the consumption of polyphenols (3, 19**). 
The biological activity of polyphenols has been explored in vivo on animal 
models and also in some clinical trials (8). Epidemiological studies have associated 
polyphenol consumption with a reduced risk of cancer and cardiovascular disease 
(20, 21). Research on the neuroprotective effects and prevention of brain ageing 
resulting from the use of dietary polyphenols has also been significantly developed in 
the last few years (21–27). 
However, PMMs may also have some important bioactivities, resulting in an 
impact on general health (19). Current information concerning their absorption and 
tissue distribution is still scarce (8, 28) and not reliable enough in order to give sound 
dietary recommendations. Additional studies are therefore needed to support the 
hypothesis that PMMs are also bioactive in the mammal organism. 
To respond to the need for knowledge about the absorption and tissue 
distribution of PPMs, focusing the attention especially on the brain, a nutrikinetics 
experiment with rats was set up. The main question was whether these metabolites 
are able to reach the brain in nutritional conditions. Thus, the in vivo trials were 
performed by injecting a nutritionally relevant dose to mimic the plasma circulating 
level of PPMs after the consumption of a bowl of strawberries. 
A detailed introduction, description of methods and discussion of the results 
are included in the manuscript ready for submission. 
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 Interestingly, the final results obtained show for the first time the simultaneous 
quantitative profile of some polyphenol microbial metabolites in rats, proving their 
distribution in the brain and the main excretory organs, i.e. the liver and kidneys, and 
in biofluids (urine and blood). 
 The question of whether the brain was a targeted organ for this class of 
molecules was resolved by first proving that some of the metabolites injected were 
already present in the brain, supporting the idea that these molecules are able to pass 
through the blood brain barrier. Moreover, in experimental conditions, with a 
nutritional amount of injected compounds (typically a sub-acute dosage), 10 out of 23 
compounds were present in significantly increased amounts.  
 
My personal involvement in this last part of the project was in the initial set up of the 
entire in vivo experiment, from evaluation of already published protocols for in vivo 
experiments and their evolution to the protocols presented, improving the reliability 
of the surgical and analytical aspects. Moreover, I was present in the surgery room at 
the Animal Facilities at the University of Trieste during the experiment for the 
management of all the procedures and the collection of the samples, in collaboration 
with Prof. Sabina Passamonti, called on to perform the surgical protocols. After 
sample collection I performed all the steps for the sample preparation, acquisition, 
processing and critical evaluation of quantitative data. As the first author I was 
responsible for writing the manuscript and managing the comments and 
improvements to the text by the other co-authors. 
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Abstract  
 
On consuming a serving of fruits rich in polyphenols a range of different 
polyphenols can be ingested, spanning from one-phenol hydroxybenzoic acid to 
more complex polymeric compounds. Only a minor part of the polyphenols (5-10%) 
is absorbed and the remainder of the reaches the colon, where they are extensively 
metabolized by gut microbiota to small molecular weight metabolites. Then the 
subsequent tissue distribution, the target organs remain largely undefined along to 
the effective circulating concentration. 
Here we report for the first time a nutrikinetics experiment testing 
simultaneously 23 polyphenol microbial metabolites following a fast time line (within 
15 min.) in rat’s organs and biofluids, with a total intravenous injected dose of 2.7 
µmol. Some of the metabolites were already find as basal level in low amount, also in 
the brain, coming from endogenous metabolism or from nutritional intake. In blood a 
pseudo-first order decay was observed with the simultaneous tissue distribution and 
excretion in the urine. Specific organ-tropisms were observed, mainly hepatotropism. 
Remarkably brain was reported in this study as one of the target organs of 
such molecules, being already present at basal level or increasing their concentration 
after the treatment. Ten out of 23 polyphenol metabolites were increased their 
concentration during the observation time in significant amount, while their 
concentration in blood was vanishing. 
Together, these results suggest a significant interplay within the gut-brain axis 
in which the polyphenol metabolites might be responsible in the alteration 
endogenous equilibrium in relationship with the nutritional intake of polyphenols. 
 
Keywords polyphenols, gut microbiota, target metabolomics, mass spectrometry, 
brain, fruit consumption  
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Introduction  
 
A diet rich in fruits and vegetables is regarded an important factor for 
protecting the human population from chronic diseases (1). Dietary recommendations 
require sound knowledge about food composition, identification of bioactive food 
components, and characterisation of their bioavailability, tissue distribution and 
elimination patterns, as well as their specific effects on the cellular homeostasis.  
Polyphenols, which are a wide and heterogeneous group of bioactive 
compounds found in plant-based foods (2), are regarded as responsible for protecting 
the human organisms from oxidative stress-related chronic diseases. However, 
polyphenols bioactivity may be much wider. Among vegetables and fruits, berries are 
the major sources of dietary polyphenols (3). 
After ingestion, only a minor part of the polyphenols (5-10%) is absorbed in 
the small intestine. The remainder reaches the colon, where they are extensively 
metabolized by gut microbiota to small molecular weight compounds (4). Gut 
microbiota consists of all the microorganisms in the intestinal tract, which is mainly 
populated by bacteria with many trillions of microbial cells (5). The metabolic 
activities of this heterogeneous bacterial population are gaining strong interest, 
because they modulate human metabolic phenotypes (6-8) and so playing an essential 
role in human health. 
The microbiota break down plant polyphenols through the actions of 
glucosidases, esterases, demethylases, dehydroxylases and decarboxylases (5,9-18), 
obtaining smaller common metabolites, such as phenolic acids and short chain-fatty 
acids (9), collectively known as polyphenol microbial metabolites (PMMs). They are 
absorbed by the colonic epithelium and found in the blood, with patterns that 
correlate with one’s diet and microbial composition of one’s microbiota (19).  
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PMMs are regarded as responsible for the healthy effects correlated with 
regular consumption of berry fruits (4,20). Epidemiological studies have associated 
polyphenol consumption with a reduced cancer and cardiovascular disease risk 
(21,22). Research on the neuroprotective effects and prevention of brain aging from 
the use of dietary polyphenols has moreover been greatly developed in the last years 
(22-28). The literature reports that diets rich in polyphenols attenuate neuropathology 
indicators and cognitive decline (25). Some studies report on a direct effect of 
polyphenols on intracellular targets, e.g. three members of the secretase family, 
known to be involved amyloidal aggregation connected with the onset and 
progression of Alzheimer’s disease (29). However, the question whether these 
compounds are able to pass the blood-brain barrier and attain there a 
pharmacologically relevant concentration is still unanswered.  
The importance of the microbiota for the brain development function has been 
pointed out by numerous studies in experimental animals (30-32), and these 
observations can be translated to human brain disorders. For instance, autism, a 
defect of brain development leading to impaired social interactions, is now being 
understood as linked to abnormal microbiota population and poor intake of fruits 
and vegetables (33). It might be speculated that PMMs are involved in normal neural 
development and function. Indeed, they are chemically identical or similar to amino 
acid and neurotransmitter catabolites.  
However, it seems that PMMs may also have some yet uncharacterised 
bioactivity, resulting in an impact on the general health status (20). Current 
information concerning the absorption and distribution of PMMS in mammalian 
tissues is still poor (9,34) and not enough to support the hypothesis that PMMs are 
the bioactive agents of our diet. Consequently, it’s not possible to work out dietary 
recommendations in favour of prevention of brain dysfunctions. 
Given this background, this study set out to characterize the time-dependent 
tissue distribution of a mixture of PMMs, following a single intravenous injection in 
anaesthetized rats. The focus of this study was on characterizing their ability to arrive 
into the brain, relative to the main excretory organs, i.e. the liver and the kidneys.  
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The data obtained show for the first time the simultaneous quantitative profile 
of several PMMs in a mammalian system, proving their distribution into the brain, 
into the main excretory organs, i.e. the liver and the kidneys, and in biofluids. For 
some PMMs, specific tropisms were also observed, highlighting for instance the 
target organs for future experimentations. Remarkably for the support of the 
neurological relevance of fruits rich in polyphenols, the data obtained show that at 
least 10 different PMMs incrementally appear in the brain within 15 min, while they 
simultaneously disappear from the blood and/or reach other organs. 
 
 
Materials and Methods  
 
 Chemicals. Phloroglucinol, pyrogallol, gallic acid, protocatechuic acid, 3,4-
dihydroxyphenylacetic acid, 4-hydroxyhippuric acid, 4-hydroxybenzoic acid, 
pyrocatechol, caffeic acid, vanillic acid, 3-hydroxyphenylacetic acid, homovanillic 
acid, 3-(4-hydroxyphenyl)propionic acid, 3-(3-hydroxyphenyl)propanoic acid, 
hydroferulic acid, trans-ferulic acid, trans-isoferulic acid, sinapic acid, m-coumaric 
acid, o-coumaric acid and p-coumaric were purchased from Sigma-Aldrich (Saint 
Luis, Missouri, USA). Isotopically labelled compounds, butyric acid-d7 and cinnamic 
acid-d5, were used as internal standard and purchased from C/D/N Isotopes Inc. 
(Quebec, Canada). Urolithin A and urolithin B were synthesized following an already 
published protocol (35) and characterized by NMR for the structure confirmation and 
purity. LC/MS formic acid, Chromasolv LC/MS methanol and acetonitrile, were 
purchased from Sigma-Aldrich (Saint Luis, Missouri, USA). 
 
 Study Design. The experiment was designed as a multi-component 
pharmacokinetic study with quantitative analysis of organs (liver, kidney, heart and 
brain) and biofluids (blood and urine). The purpose was for the exploration of the 
fate of polyphenol microbial metabolites mixture in a mammalian system. The 
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experiment was divided into four different time point: 15 seconds, 2 minutes, 5 
minutes and 15 minutes (Figure 1). Each time point was represented by 4 replicates, 4 
rats received the dose with the polyphenol microbial metabolites, and one blank rat, 
as control, without polyphenol metabolites mixture but with identical experimental 
procedure. 
Twenty male rats (Rattus norvegicus, Wistar, Harlan Italy S.r.l.) were bred at the 
animal facility of the University of Trieste. The experiment was approved by the 
bioethical committee of the University of Trieste (doc. 865PAS12). The experiments on 
the animals were carried out in compliance with the provisions of the European 
Community Council Directive. Rats (n=20) at the same age (12 weeks) and weight 
(288 ± 20 g) were maintained in temperature-controlled rooms at 22-24 °C, 50-60% 
humidity and 12 hours light/dark cycles. They were fed until the night before the 
experiment with standard laboratory chow. 
During the in vivo experiment the rats were kept under quiet conditions. The 
cages were covered with cloth and so they were either sleeping before the anaesthetic 
injections or were awake but without little apparent nervous behaviour. After the 
anaesthetic the animals were left alone to fall asleep in another cage, also covered. In 
all cases the animals’ conditions were monitored.  
 
 Polyphenol Microbial Metabolites Mixture for Intravenous (I.V.) 
Administration. The polyphenol metabolites mixture was made up of 23 different 
metabolites selected from among the product of polyphenol metabolism by gut 
microflora after the consumption of berry fruits. The metabolites were selected by the 
literature and the dosage for each metabolite was chosen while seeking to maintain 
the same levels and ratios as reported in the literature. Each metabolite was dissolved 
in methanol and then mixed together accordingly to the diverse selected amounts. 
Detailed information regarding the polyphenol metabolites mixture dosages is given 
in Figure 2. 
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 Treatment of Rats. The rats were divided into two groups for a two-day 
experiment, with 2 pharmacokinetic time point per day. The first day, time points 15 
min. and 2 min. were performed. Time points 5 min. and 15 sec. were performed in 
the second day. The night before the experiment, the rats (10 animals) were starved 
overnight, but provided with water ad libitum. They were divided into 5 different 
cages for the experiment. 
The rats were anaesthetised with intra-peritoneal administration of 
Tiletamine/Zolazepam (1:1, 25 mg/kg body weight) and Xylazine (10mg/kg body 
weight). The Rat received an i.v. administration of 0.3 mL PBS (phosphate buffer 
solution), with 2.7 µmol of polyphenol metabolite mixture, dissolved in 30 ul of 
methanol. The blank animals, used as controls for each time point, received an i.v. 
injection of 0.3 ml of PBS with 30 ul of methanol to maintain the same volume and 
same condition as the treated animals.  
During anaesthesia (10 min in all cases), the heart and ventilation rate were 
controlled. The rats were placed on their backs; the penis was extruded by sliding the 
prepuce downwards. With the use of a nipper the glans penis was held at the tip. The 
dorsal penis vein was then seen and exactly 10 min. after anaesthesia 0.3 ml PBS with 
(treated) or without (blank) 2.7 µmol of polyphenol metabolite mixture was injected 
using an insulin syringe. Then the injection site was pressed for a few seconds, and 
the glans was retracted to prevent bleeding (36). After the PBS injection one min. 
before the sacrifice of the rat - at the end of each time point - sodium heparin (0.1 ml, 
500 IU) was injected again into the dorsal penis vein, which was exposed in the same 
way. For the time point 15 sec. the procedure was slightly different, after 10 min of 
anaesthesia 0.2 ml PBS and 0.1 ml sodium heparin with (treated) or without (blank) 
2.7 µmol of polyphenol metabolite mixture was injected at the same moment using an 
insulin syringe. 
Exactly 10 min after anaesthesia and the corresponding time point after i.v. 
administration (15 sec., 2 min., 5 min., and 15 min.), the rats were sacrificed by 
decapitation. Blood was drained from the body. Urine was collected through the 
urinary bladder with a syringe. Liver, kidney, heart and brain were excised from the 
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body, washed with MilliQ water and immediately frozen in liquid nitrogen and 
stored at -80 °C. 
 
 Organs Collection and Extracts Preparation. Biofluids. After sampling, an 
aliquot of blood (5 ml) was transferred into aqueous methanol (95:5, v/v) in a ratio of 
1:9 (v/v). Cinnamic acid-d5, as internal standard, was dissolved in aqueous methanol 
at a concentration of 0.1 mg/L for the monitoring of the extraction protocol. The 
sample was shacked and extracted for 10 min. The extract was then centrifuged for 5 
min at 3600 rpm at 4 °C, blood extract with the buoyant (non-cellular) portion was 
transferred to 50 ml dark glass vessels and stored at -80 °C (37). 
In the same way an aliquot of urine collected with a syringe was extracted 
with aqueous methanol (95:5, v/v). The urine was weight and the amount of solvent 
for extraction was adjusted to the ratio 1:9 (w/v). The urine was centrifuged and then 
transferred to 10 ml dark glass vessels and stored at -80 °C. Biofluid samples after 
solvent extraction were ready for the subsequent clean-up purification protocol for 
the injection in the UPLC-MS/MS system. 
 Tissues. Organs, frozen in liquid nitrogen immediately after excision, were 
stored at -80°C. Frozen liver, kidney, heart and brain were grounded under cryogenic 
conditions, using liquid nitrogen, with a CryoMill (Retsch, Germany) using a single 
25 mm i.d. steel ball (30 sec. with a frequency of 25/sec.). Tissue powder (1 g) was 
transferred (without thawing) into aqueous methanol (5:95 v/v) at a ratio of 1:9 
(w/v). Cinnamic acid-d5, as internal standard, was dissolved in the aqueous 
methanol at a concentration of 0.1 mg/l for the monitoring of the extraction protocol. 
The samples were extracted with an orbital shaker for 10 min., centrifuged and 
decanted, as described for blood (37). The final volume was then adjusted to 10 ml to 
balance any possible variation in the amount of water among the organs and stored at 
-80 °C. Tissue samples after solvent extraction were ready for the clean-up 
purification protocol before injection in the UPLC-MS/MS system. 
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 Solid Phase Extraction (SPE) Purification and Sample Preparation. SPE 
protocol was applied following a procedure developed by Passamonti et al. (38), but 
with some modifications and as validated by Gasperotti et al. (Chapter 2.1). The 
cartridges used for the SPE purification were Biotage Isolute ENV+, 1 g (Uppsala 
Sweden).  
An aliquot of extracted sample (5 mL), was evaporated and reconstituted with 
10 ml of H2SO4 0.01 N in water. The conditioning of cartridges was carried out using 
20 ml of methanol and 20 ml of H2SO4 0.01 N in water. After loading the sample, the 
cartridges were washed with 10 ml of Milli-Q water, dried under a nitrogen stream 
and eluted with 20 ml of methanol. The eluates were evaporated to dryness and the 
samples were dissolved in 500 µL of methanol/water (50:50 v/v). Butyric acid-d7, as 
internal standard, was dissolved in the methanol/water (50:50 v/v) at a 
concentration of 1 mg/l and added to the sample for the monitoring of quantitative 
recovery during sample reconstitution. Samples were filtrated with a 0.22 µm filter 
and injected in the UPLC-MS/MS system. 
 
 Targeted Metabolomics Analysis. Targeted metabolomics analysis was 
performed with an ultra performance LC (UPLC) system coupled to a triple 
quadrupole (TQ) mass spectrometer. The UPLC system used was a Waters Acquity 
UPLC system (Milford, Massachusetts, USA). Separation of the 23 target metabolites, 
and 2 deuterated internal standards was performed with a Waters Acquity UPLC 
column (Milford, Massachusetts, USA), HSS T3 (100mm x 2.1mm, 1.8 µm) equipped 
with the proper guard column. The injection volume was 10 µL. Mobile phases of 
0.1% formic acid in Milli-Q water (A) and 0.1% formic acid in acetonitrile (B) were 
used. Chromatographic separation was performed using a gradient as follows: 0 min, 
5% B; 0-3 min, 5%-20% B; 3-4.30 min; 20% B; 4.30-9 min, 20%-45% B, 9-11 min, 45%-
100% B, 11-14 min, 100%; and 14.01-17 min, 5% as equilibration time. The TQ mass 
spectrometer used was a Waters Xevo TQ (Milford, Massachusetts, USA) coupled 
with an electrospray interface. The two most abundant fragments were selected for 
each metabolite to establish a MRM (multiple reaction monitoring) quantitative 
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method. The first transition, corresponding to the most abundant fragment, was used 
as quantifier ion, and the second as qualifier ion. Detailed information regarding the 
UPLC-MS/MS method and quantification are described in Gasperotti et al. (Chapter 
2.1). 
 For calibration, a standard mixture of polyphenol metabolites was serially 
diluted in aqueous methanol (50:50), in a concentration range 0.01 µg/L - 100 mg/L. 
The range of calibration curves was obtained on the basis of the linearity of the 
responses. Acceptable linearity was achieved when the coefficient of calibration 
curves (R2) was at least 0.99. Quantitative data were processed with Targetlynx 
software (Masslynx, Waters). Quality control acquisition, recovery and data 
variability information are reported in the supplementary material. 
 
 Blood Residual Subtraction for the Brain Samples. The concentrations in the 
rat brain may be significantly influenced by the quantities of metabolites in the 
residual blood. The correction was made by estimating the amount of metabolite in 
the intravascular blood present in the brain, assuming that the volume of blood brain 
is 47.7 µL/g (39) and then subtracting this from the total amount found in the brain. 
The results of this subtraction are presented in Figure 4 compared also with the data 
of the brain before the blood residual subtraction. 
 
 Calculation of Pharmacokinetics Parameters. Pharmacokinetics parameters 
were calculated using the GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA) 
with the function one phase decay suitable for I.V. injection experiments. For each 
metabolites detected and quantified in blood, the extrapolated dose at time 0 (t0), the 
dose at the steady state (t∞) were obtained from the plotted curves. The area under 
the curve (AUC 0

15 min.) and the elimination rate (Ke) were also obtained from the 
plotted curves. 
 
 Statistical Analysis. The quantitative data for the PMM levels are presented as 
mean values ± standard error (n = 4) for all the graphs. Difference between time 
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points in the brain, compared with the control were evaluated by the Student’s test, 
with p < 0.1 considered statistically significant. 
 
 
Results and discussion 
 
 The Tested Mixture of Polyphenol Microbial Metabolites: a Rational Choice. 
The strategy was to simultaneously inject 23 metabolites, composing a well-defined 
mixture (figure 1), in a single animal. The metabolites were chosen for being products 
of the gut-microflora metabolism of polyphenols occurring in berries (11–13, 17, 40). 
Their individual concentrations in the mixture were chosen to mimic their average 
plasma concentration, after a putative intake of a regular berry fruit serving (41). All 
individual molecules are commercially available, except for urolithin A and B. The 
latter are regarded as specific biomarkers of gut microbial metabolism of dietary 
ellagitannins. They were synthesized in house (35). 
An analytical method, based on UPLC-MS/MS, enabled to simultaneously 
measure this set of compounds in biological fluids and tissue extracts from a single 
rat, achieving a remarkable reduction of experimental animals, as recommended by 
regulatory bodies (42).  
The in vivo injection of a multi-component mixture could give rise to certain 
problems. Some metabolic pathways could transform some metabolites into other 
compounds already present in the mixture, so altering the chemical composition of 
the injected mixture. Moreover, the simultaneous injection of different metabolites 
could affect the rate of membrane transporters, enzyme pathways or cellular 
regulatory mechanisms, resulting in competitive interactions, rapid states of 
saturation or cooperative responses, just to mention a few cases. Nevertheless, the 
injection of a multi-component mixture offered the possibility to simultaneously 
assess the fate of each compound, so closely simulating a nutritionally relevant 
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scenario in blood, even if in the presence of other congeners or further metabolites not 
observed. This was the main goal of the study. 
It should be therefore appreciated that this mixture was designed to represent 
what results from two principal biochemical processes of the mammalian digestive 
tract after the dietary intake of fruits rich in polyphenols (Figure 2, panel A.). The first 
one is the transformation of a raw mixture of dietary plant polyphenols by the gut 
microflora, yielding a digested extract. In this scenario the gut microflora represents 
the connection or the mediator between plant and mammalian systems. The second 
one consists in the selective transport of the digested extract across the intestinal 
epithelial barrier, which can be regarded as a filter, into the blood, and the 
subsequent tissue distribution. 
 
 Dosage, Route of Administration and Time-line: a Strategy for an Accurate 
Tissue Distribution Analysis. The most accurate approach to study the tissue 
distribution of PMMs is to administer the PMMs by intravenous injection, so to avoid 
the main factors of inter-individual variability of gut metabolism and absorption (6). 
Any other downstream process, such as distribution into tissues and eventual 
metabolism is comparatively more homogenous among individuals (43) allowing to 
attain a satisfying variation coefficient in all measured parameters using reduced 
numbers of animals (n=4). 
The injected dose was 2.7 µmol, resulting from the sum of 23 individual 
amounts of PMMs (Figure 1), spanning from 0.9 µmol (gallic acid) to 0.0005 µmol 
(sinapic acid). Considering that the rats (body mass=288±20 g) had an estimated 
blood volume of 16 ml (44) and assuming that all the mixture components has free 
access to the internal volume of blood cells, the initial blood concentration was 168 
µM, spanning from 56.25 µM (gallic acid) to 0.31 µM (sinapic acid). These values are 
within the concentration range observed in humans following consumption of a 
standard serving of berry fruits (45). 
An overview of the time-line and the analytical procedure, from sample 
preparation to instrumental analysis, for the data acquisition of the experiment is 
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graphically presented in Figure 1, panel B. The experiment was designed on the basis 
of previous data showing the exceptionally fast uptake and metabolism of a dietary 
flavonoid, i.e. cyanidin 3-glucoside, an ubiquitous pigment in red fruits (43). It was 
assumed that the plasma disappearance kinetics of low-molecular weight metabolites 
of flavonoids and other dietary polyphenols should follow a quite similar pattern. 
The site for the intravenous injection of the PMMs mix was the dorsal penis 
vein, easily accessible through a thin epidermal layer and afferent to the general 
circulation (36). The minimal manipulation of an anaesthetized animal is seen as a 
crucial factor, since any inflammation mediator locally released following a surgical 
trauma might affect the permeability of the blood-brain barrier and/or the basal 
functions determining distribution (i.e. membrane transporters), metabolism (i.e. 
enzymes) and excretion (again, membrane transporters). 
The choice of the time points seems appropriate for a reasonable description of 
the time course of both disappearances of the injected molecules from the blood and 
their presence into the organs and the urine. Under the chosen conditions, the 
animals experienced minimal duration of anaesthesia and of physical stress. Overall, 
this experiment is a refinement of previous protocols adopted by us (37, 43). 
 
 The Presence of Basal Levels of the Mixture Components in Control 
Animals. Many of the mixture components arise not only from the microbial 
metabolism of dietary polyphenols, but also from mammalian catabolism of 
endogenous substrates (41). Thus, some are expected to occur in the rat organs and 
fluids at basal levels in control animals. Compounds that are exclusive products of 
microbial metabolism, for instance, are the urolithins, the ferulic acids, gallic acid, 
coumaric acids and protocatechuic acid (41). However, also these might be expected 
to occur in control animals, being markers of a normal nutritional status, like, for 
instance, ferulic acid. The basal levels of the 23 mixture components were in general 
very low. Exceptions are mentioned case by case below. 
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 Tracing Polyphenol Metabolites in Blood. The blood of control rats contained 
11 out of the 23 injected molecules. Of these endogenous compounds, see Table 1, six 
were less than 1% of the amount occurring in the injected mixture, other 3 were less 
than 2%. The 2 outliers were p-coumaric acid (3.3%) and phloroglucinol (17.8%). 
Thus, the selected mixture represented a valid challenge for a pharmacokinetics test, 
because of these very low basal levels. This test seemed to reliably simulate what 
happens in the organism after consumption of a typical berry fruit serving, after a 
short period of “wash out”.  
Most injected compounds disappeared following apparent pseudo-first order 
kinetics, as shown in Figure 3. The calculated parameters, i.e. the extrapolated 
amounts at time zero (t0) and at steady state (t∞), and the disappearance rate constant 
(ke) are listed in Table 1 according to the value of ke, which spanned from 2.73 to 0.38 
min-1 (t/2=0.25 to 1.84 min), pointing to a quite rapid process. There were a few 
exceptions. 
One compound, i.e. pyrogallol, could never be detected, though its recovery 
and analysis posed no specific issues; the mechanisms whereby it underwent 
disappearance cannot be guessed. Two compounds, i.e. pyrocathecol and 3,4-
dihydroxyphenyl acetic acid, were detected only at 15 sec. Urolithin B, detected at 
very low levels at both 15 sec and 2 min, rose thereafter by an order of magnitude. 
Phloroglucinol occurred at a similar level during the entire experiment. 
With the above-mentioned few exceptions, steady state values were attained 
even earlier than 5 min, so assuring that the duration of the experiment was 
appropriate. In most cases, the compounds were essentially disappeared at 15 min. 
The calculated amounts at t0, and the amounts at any time points, were always 
lower that the sum of the injected dose and the endogenously present compound in 
control samples, if any. Expressed as percent of the injected amounts in Table 1, the 
calculated t0 ranged from 43.5 % (m-coumaric acid) to 1% (gallic acid). This is no 
longer surprising; having already seen how fast is the uptake and excretion of one of 
the precursors of these metabolites, i.e. the fruit pigment cyanidin 3-glucoside (43).  
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An explanation of the loss of part of the injected dose and of the extremely 
rapid blood disappearance may be a quick uptake and distribution in organs. Only 
some major organs were collected, thus an accurate recovery assessment cannot be 
provided. The compounds might have also distributed in large tissues, such as the 
adipose tissue, the vascular endothelium, or the connective tissue. Moreover, the 
administered compounds could be metabolically transformed, but these were not 
analysed in this experiment, which is the first attempt of a simultaneous kinetic 
characterization of 23 polyphenol metabolites. 
  
 Polyphenol Microbial Metabolites in the Brain. The main findings concerned 
the detection of PMMs in the brain, at times when their blood concentrations were 
vanishingly low (Figure 4). Each plot shows 2 curves, representing the total amounts 
measured in whole brains (dot line) and those corrected for blood residual (solid 
line), as recommended (39, 46–48). Indeed, brains were not perfused to wash out the 
blood, since this procedure would have altered the chemical equilibrium between the 
vascular compartment and the whole brain.  
The more so since 13 out of 23 compounds of the mixture were found in the 
control brains, as endogenous metabolites (Table 2). Disregarding the time of 
observation, 10 compounds out of 23 where found in the brain at a significantly 
increased amount with respect to the control (Table 2). In most cases, their 
appearance in the brain was biphasic, with an early wave at 2 min, with 4 
compounds, and a second one starting at 5 min; at 15 min, 9 compounds were 
detected. Gallic acid, which was the most abundant compound in the mixture (Fig. 2) 
best showed this bi-phasic accumulation trend. Noteworthy, it accumulated in the 
brain by about 11 times above the basal concentration measured in the control as 
early as 15 sec.  Similarly, caffeic acid had two peaks, and accumulated by ca. 20 and 
34 times at 2 min and 15 min, respectively (Table 2).  
Importantly, two compounds were neither detected in the brain as 
endogenous metabolites nor ever appeared in the brain, i.e. trans-isoferulic acid and 
o-coumaric acid, in spite of their relatively low plasma elimination rate constant, so 
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proving that the blood-brain barrier was intact during the experiment. Other 
endogenous compounds never increased their concentration in the brain, i.e. 
protocatechuic acid and phloroglucinol. 
Those compounds that accumulated in the brain should be active, because in 
all cases, except for urolithin B, they were also endogenous metabolites already 
present in the control brains. Their most predictable effect is unbalancing a pre-
existent metabolic equilibrium. Ferulic acid, accumulated at 15 sec in the experiment, 
is reported to be able to reduce oxidative damage and amyloid pathology in 
Alzheimer’s disease (49). Some PMMs are identical to metabolites of 
neurotransmitters. For instance, vanillic acid and homovanillic acid are catecholamine 
catabolites, found in the in brain and in cerebrospinal fluid (50). Moreover, 3,4 
dihydroxyphenyl acetic acid is neuronal metabolite of dopamine and involved with 
the dopamine catabolism in the pathogenesis of Parkinson's disease (51). Another 
mechanism of action is by affecting enzyme kinetics. For instance, caffeic acid may 
bind to tyrosine ammonia lyase, thus altering serotonin homeostasis (52), or by 
inhibiting acetylcholinesterase and butyrylcholinesterase activities and as 
consequence preventing oxidative stress-induced neurodegeneration (53). Gallic acid 
has also demonstrated activities on key enzyme activities in the brain (26, 54) and 
able to accumulate in the brain after repeated dose (55). 
 
 Polyphenol microbial metabolites in other organs. The analyses of PMMs in 
the heart, the liver, the kidneys, and the urine are shown in Fig. 5 (and in 
Supplementary Figures 1-4). Eighteen out of 22 compounds attained quite high 
concentrations in the urine (Figure 5, Supplementary Figure 1), with the exception of 
pyrocatechol and urolithin B, which were not found in the urine, urolithin A, which 
concentration slightly increased, and phloroglucinol, which did not change with 
respect to the value found in control animals. Thus, most PMMs can be defined as 
nephrotropic. Indeed, 20 out of 22 compounds dramatically increased their 
parenchymal concentrations from basal values of zero or close to zero up to values 
higher by at least 2 orders of magnitude (Figure 5, Supplementary Figure 2). For this 
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extraordinary velocity, the apparent rate of accumulation in the kidneys could not be 
calculated. Accumulation lasted no more than 2 min and often less, after which time 
their concentration started decaying. By contrast, the appearance in the urine was 
slower, with a lag phase lasting 15 sec before the onset of urinary excretion, seen in 
most cases (20 out of 22).  
Only a few compounds were found to be rather hepato- than nephrotropic, 
such as phloroglucinol, urolithin A and 4-hydroxybenzoic acid (Figure 5, 
Supplementary Figure 3). One compound (sinapic acid) could not be detected in the 
liver for 3 consecutive times, at which it was however present in the blood. Thus, the 
amount of blood retained in the organ was absolutely negligible. Similarly, the basal 
levels of 3-(3-hydroxyphenyl)propanoic acid did not change in the liver, in spite of its 
presence in the blood at concentrations higher by 2 orders of  magnitude.   
Only 3 compounds were found to be cardiotropic, i.e. vanillic acid and both 
urolithins (Figure 5, Supplementary Figure 4). They accumulated to a maximum 
concentration at 15 sec, but then vanillic acid and urolithin A disappeared, whereas 
urolithin B started to increase again at 5 min. Three compounds (phloroglucinol, 3,4-
dihydroxyphenyl acetic acid and pyrocatechol), though present in the blood, could 
not be detected in the heart, showing the negligible blood contamination. 
The low apparent hepatotropism of most PMMs leads to conclude that PMMs 
absorbed from the colon under normal conditions undergo limited first-pass 
metabolism into the liver, so that they can distribute to the other organs readily after 
absorption. Then, they are eliminated in the urine after prior accumulation in the 
kidneys. Only one compound, i.e. 4-hydroxybenzoic acid, appeared in the urine at 15 
sec, likely by glomerular filtration. 
 
 The Case of Urolithins. Urolithins are the largest molecules among the PMMs 
(Figure 1), arising from microbial metabolism of ellagitannins and ellagic acid 
conjugates (56). Urolithin A differs from urolithin B for the one additional hydroxyl 
group. No other mammalian enzyme pathway is known to produce such end-
products from more complex precursors. In facts, none of them was detected in the 
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organs of control animals. Urolithin A and B were administered at different doses, i.e. 
55 and 25 nmol, respectively.  Nevertheless, their concentrations in the blood differed 
by an order of magnitude at 15 sec (332.6 and 20.3 pmol/ml, respectively). Thus, 
urolithin B was sequestered (and/or metabolized) more rapidly then the other in the 
tissues.  
Both of them displayed a unique pattern of blood concentration, tissue 
distribution and urinary excretion. Indeed, though urolithin A had a normal mono-
exponential disappearance from the blood, urolithin B, increased in the blood after 2 
min from a very low level (see above). It seems, therefore, that urolithin A underwent 
a so unusual as mechanistically unexplained de-hydroxylation reaction. Only 
bacterial de-hydroxylases are known. 
Both of them were negligibly excreted in the urine, unique cases among the 
PMMs. They were presumably excreted as glucuronyl derivatives (11), which were 
not analysed. Rapid uptake of urolithin A into the kidneys was observed, whereas 
urolithin B appeared in the kidneys only later than 2 min, i.e. when it was also 
present in the blood. The liver slowly took up urolithin A up to 5 min, but no 
urolithin B could be detected there for 15 min. This shows that the liver could neither 
convert urolithin A to urolithin B, nor take the latter up from the blood. 
The organ that displayed the highest capacity in this sense was the heart, 
where both urolithin A and B were found at 15 sec, at about 300 and 2000 pmol/g, 
respectively. It seems therefore that the following happened: i) urolithin A was 
rapidly (by 15 sec) taken up into the heart and de-hydroxylated to urolithin B by 
unknown enzyme(s); in the heart, both urolithins could be converted to other 
compounds, that were not followed; ii) urolithin B was released from the heart into 
the blood, where indeed it raised from 2 min to 5 min; iii) from 5 min on, the tissue 
concentrations of urolithin B increased at higher levels than in the blood. 
 Urolithins have a demonstrated activity in reducing glycation of proteins (57) 
in neuronal cell, and possibly even in the heart. In facts, the advanced glycation 
endproducts, deriving from the glycation reaction in heart and vascular tissue are 
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responsible of the reduction of artery and heart elasticity and have a role in the 
progression of cardiovascular complication associated with diabetes (58). 
 
 Is the Brain a Target of Polyphenol Metabolites? The findings would tell so. 
First, not less than 13 PMMs were found at basal levels in control brains and this is 
the first report, to our knowledge. As a consequence, the possibility of their passage 
through the blood-brain barrier must be assumed a priori, as a process to ensure their 
exchange with the blood compartment.  
Ten out of 23 were found significantly increased after the injection of the 
PMMs mixture in the treated animals. Some of them might have an exquisite dietary 
origin, such as gallic acid or t-ferulic acid. Others could instead be catabolites of 
endogenous compounds, such as catecholamine, dopamine, aminoacids and others. 
Fig. 6 highlights the concentrations of gallic acid attained in all the organs considered 
at various times. The brain shows a clear capacity to extract gallic acid from the 
blood, even higher than the liver. On the contrary, the tightness of the blood-brain 
barrier is demonstrated by its absolute impermeability to o-coumaric acid, in spite of 
its higher hydrophobic index (logP: 2.45, while gallic acid logP is 0.91). Yet, both 
gallic acid and o-coumaric acid occurred in the blood at similar concentrations.  
These data provide further health implications of the brain-gut microbiota axis (53), 
highlighting how PMMs could be one of the putative connections/messengers 
between microflora and brain. These bidirectional interactions, for instance was 
already explored highlighting the importance of the gut microbiota for brain 
development and behaviour (54), or for the influence on anxiety and depression (55). 
Being the PMMs the product of the dietary intake of polyphenols and the metabolism 
of the gut microflora, it is reasonable to assume that those compounds might be able 
to regulate the human health and disease state (56). Moreover the role of the gut 
microbiota in the alteration of mammalian blood metabolite levels was already 
demonstrated combining data from germ free and conventional animals (57). Their 
action might be in the reduction of oxidative stress, but more likely in the modulation 
of biochemical and physiological processes, changing the level of endogenous 
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compounds also in the brain, along with other organs as observed in the present 
study. 
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Figure 1 Mixture of polyphenol microbial metabolites used for the intravenous 
injection, their chemical formula, molecular weight (MW), dose and relative 
percentage on the total amount injected, 2690 nmol (dosage:168.13 µM) 
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Figure 2 Panel A. represents the main biochemical processes of the mammalian 
digestive tract, from the transformation of a raw mixture of dietary plant polyphenols 
by the gut microflora, yielding a raw mixture of polyphenol metabolites and their 
distribution, after the passage through the intestinal epithelial barrier. Panel B. 
represents the time points observed for the kinetics and the main surgical and 
analytical steps for the acquisition of the quantitative information. 
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Figure 3 Polyphenol microbial metabolites in blood and their pharmacokinetic 
profiles 
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Figure 4 Polyphenol microbial metabolites in brain and their profiles. Dotted lines are 
referred to the amount found in the whole brain, while continuous lines are the data 
after the subtraction of the blood residual in the brain. Data with the asterisk are 
significantly increased from the control samples (p < 0.1). 
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Figure 5 Polyphenol microbial metabolites in liver, kidney, urine and heart and their 
profiles. 
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Figure 6 Profile of gallic acid and o-coumaric acid in brain, liver, kidneys and blood. 
 
 
 
 
Figure 7 Profile of urolithin A and B in all the organs considered for the experiment. 
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Table 1 Percentage of recovery in blood compared to initial injected dose and 
pharmacokinetic analysis of polyphenol microbial metabolites. For the recovery the 
values given are the percentages of dose found in rats after the i.v. injection at four 
different time points (t0.25, t2 ,t5, t15 min.) and control, sd is the standard deviation of 4 
replicates. For t0 the percentage reported is an extrapolation based upon the 
pharmacokinetics curves associate to a first order exponential decay for an i.v. 
injection.  
 
         Time Points (min.)  Pharmacokinetics 
 
dose t0 * t0.25 t2 t5 t15 Control 
 
Steady 
state t=∞ 
AUC        
(0 →15) 
k e 
  
nmo
l 
% average recovery % ± st. dev. 
  
pmol/ml 
pmol*mi
n/ml 
min-1 
4-hydroxyhippuric acid 250 13.3 11.7 5.5 13.4 6.2 6.4 6.1 2.4 0.6 0.0 0.0  0.00 15017 0.09 
3-hydroxyphenylacetic acid 150 19.9 18.6 6.2 10.5 2.7 6.5 1.5 3.0 1.6 0.6 0.2  304.50 9238 0.38 
homovanillic acid 50 18.7 17.5 5.2 8.8 0.8 7.0 1.7 3.0 1.2 0.4 0.3  118.40 3022 0.45 
o-coumaric acid 15 34.6 32.0 11.1 15.7 2.3 12.1 2.8 5.2 2.3 0.1 0.1  62.70 1597 0.47 
trans-isoferulic acid 35 25.9 23.2 7.1 9.3 1.8 7.0 2.3 1.9 1.0 0.0 0.0  73.40 2125 0.58 
4-hydroxybenzoic acid 100 18.5 16.3 5.3 6.5 0.6 3.8 1.5 1.5 0.4 1.7 0.9  131.50 3864 0.62 
vanillic acid 50 18.7 16.3 7.6 6.4 1.8 3.9 1.5 1.8 0.4 1.3 0.5  75.70 1992 0.67 
3-(4-hydroxyphenyl)propionic acid 100 24.8 21.9 6.4 10.1 1.0 8.4 2.2 4.6 1.1 0.4 0.5  371.50 7538 0.69 
urolithin A 55 11.5 9.7 3.3 2.9 0.9 0.8 0.1 0.1 0.1 0.0 0.0  9.80 733 0.71 
3-(3-hydroxyphenyl)propanoic acid 450 15.5 13.5 3.6 5.7 0.8 5.1 0.8 2.2 0.6 0.8 0.6  929.30 19569 0.72 
p-coumaric acid 15 22.2 19.3 5.0 7.9 1.3 6.6 1.3 3.0 1.1 3.3 5.4  40.50 872 0.74 
trans-ferulic acid 60 18.0 14.7 5.9 3.8 0.5 1.9 0.7 0.5 0.5 0.0 0.1  39.30 1387 0.88 
caffeic acid 60 1.8 1.4 0.5 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0  2.53 108 0.95 
sinapic acid 5 14.5 11.6 4.8 2.8 0.3 1.2 0.1 0.6 0.7 0.0 0.0  2.40 84 0.95 
hydroferulic acid 75 19.3 15.7 5.7 4.6 0.4 3.6 1.2 1.2 0.7 0.1 0.1  105.30 2535 0.96 
m-coumaric acid 15 43.5 35.1 12.6 9.8 1.5 6.8 2.9 2.7 1.8 0.0 0.0  41.60 1044 0.97 
protocatechuic acid 65 8.5 6.6 1.2 3.3 0.5 4.0 3.9 2.4 0.7 1.4 0.1  129.70 2101 1.72 
gallic acid 900 1.0 0.6 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0  72.40 1296 2.73 
phloroglucinol  100 26.3 23.0 5.8 26.2 4.1 22.8 10.8 17.7 9.8 17.0 6.7  § 19951 § 
3,4-dihydroxyphenyl acetic acid 75 § 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0  § 13 § 
pyrocatechol 15 § 1.0 0.9 1.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0   § 35 § 
urolithin B 25 § 1.3 1.0 0.4 0.2 9.4 4.2 9.3 12.4 0.0 0.0  § 1721 § 
* extrapolated value from the pharmacokinetic curves for the dose at time zero. 
§ no available extrapolated data due to the non fitting with the proper 
pharmacokinetic curves associated to an i.v. injection.  
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Table 2 Endogenous amounts of polyphenol metabolites in control brain and 
polyphenol metabolites significantly increased compared to control brain at any time 
points (p<0.1). 
 
 dose control t0.25 t2 t5 t15 
fold of 
change 
t2/control 
fold of 
change 
t15/control 
  nmol pmol/g   
4-hydroxyhippuric acid 250 5.52    20.06  2.63 
3-hydroxyphenylacetic acid 150 n.d.       
homovanillic acid 50 314.81    433.16  0.38 
o-coumaric acid 15 n.d.       
isoferulic acid 35 n.d.       
4-hydroxybenzoic acid 100 126.63  206.97  407.92 0.63 2.22 
vanillic acid 50 99.71    384.71  2.86 
3-(4-hydroxyphenyl)propionic acid 100 3.88       
urolithin A 55 9.72       
3-(3-hydroxyphenyl)propanoic acid 450 119.01    192.81  0.62 
p-coumaric acid 15 18.34       
trans-ferulic acid 60 6.34  27.01   3.26  
caffeic acid 60 0.11  2.36  3.81 20.45 33.64 
sinapic acid 5 n.d.       
hydroferulic acid 75 n.d.       
m-coumaric acid 15 n.d.       
protocatechuic acid 65 183.40       
gallic acid 900 52.17 573.00 612.72 265.97 610.82 10.74 10.71 
phloroglucinol  100 1373.36       
3,4-dihydroxyphenyl acetic acid 75 291.82    501.19  0.72 
pyrocatechol 15 n.d.       
urolithin B 25 n.d.     2.09 2.50  > 2.50 
         
compounds increased at any time  
(p<0.1)   1 4 2 9   
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Supplementary Material 
 
 
 Quality Control Acquisition, Recovery and Data Variability. For each 
individual sample, the quality of sample preparation (extraction and purification) 
and analytical performance (acquisition) were constantly monitored through the 
quantitative results of two internal standards and polyphenol metabolite mix injected 
every 10 biological samples during instrumental analysis. The relative standard 
deviation (RSD %) for the entire batch sequence in all samples (n=126) as regards the 
two internal standards was 15 % and 14 %, respectively for butyric acid-d5 and 
cinnamic acid-d7. In the case of the standard mix injections (n=14), with every 10 
samples, there was a relative standard deviation below 16 % for all polyphenol 
metabolites. Detailed information about quality control acquisition are reported in 
Supplementary Table 1. 
The instrumental method used for the detection and quantification of the 
polyphenol metabolites was already validated and published by Gasperotti et al. and 
the recovery in all matrixes was validated (Chapter 2.1). Quantitative data for each 
metabolite was thus normalized with the corresponding recovery value in the 
different validated biological matrixes. 
The control animals not injected with the polyphenol metabolites mix can be 
considered 4 control replicates. The short kinetics trials time did not affect the results 
of the control animals in terms of already present endogenous metabolites. 
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Supplementary Figure 1 Polyphenol microbial metabolites in urine and their profiles. 
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Supplementary Figure 2 Polyphenol microbial metabolites in kidneys and their 
profiles.
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Supplementary Figure 3 Polyphenol microbial metabolites in liver and their profiles. 
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Supplementary Figure 4 Polyphenol microbial metabolites in heart and their profiles. 
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 Supplementary Table 1 Quality control acquisition  
         
 standards mix  (n=14)   internal standards (n=126) 
  
mean 
(mg/L) 
s.d. CV%   
mean 
(mg/L) 
s.d. CV% 
t-cinnamic acid d5 - IS     0.78 0.12 15 
butyric acid d7 - IS     1.06 0.15 14 
phloroglucinol 1.03 0.04 4     
gallic acid 1.01 0.06 6     
pyrogallol 0.96 0.04 4     
protocatechuic acid 0.94 0.06 6     
3.4-dihydroxyphenyl acetic acid 0.99 0.03 3     
4-hydroxyhippuric acid 0.95 0.07 8     
4-hydroxybenzoic acid 0.96 0.03 4     
pyrocatechol 0.97 0.07 7     
caffeic acid 0.92 0.06 7     
vanillic acid 0.94 0.05 5     
3-hydroxyphenylacetic acid 0.86 0.10 11     
homovanillic acid 0.98 0.04 4     
3-(4-hydroxyphenyl)propionic acid 0.99 0.06 6     
p-coumaric 0.98 0.04 4     
hydroferulic acid 0.86 0.07 8     
3-(3-hydroxyphenyl)propanoic acid 0.96 0.06 6     
trans-ferulic acid 0.98 0.04 4     
sinapic acid 0.78 0.12 16     
m-coumaric acid 0.98 0.03 3     
trans-isoferulic acid 0.98 0.06 6     
o-coumaric acid 0.94 0.05 5     
urolithin A 0.97 0.02 3     
urolithin B 0.80 0.06 8         
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 The main aim of this Ph.D. project was on the one hand to study a plant 
system, with molecular characterisation of polyphenol composition, and on the other 
hand bioavailability in the mammalian system. The link between these two systems, 
or between the two plant and mammalian metabolomes, is represented by the 
microbiota. Indeed the gut microbiota could be considered as an intermediary, being 
responsible for the alteration/improvement of the mammalian metabolome via the 
plant metabolome after nutritional intake and involved in shaping the variety of 
exogenous metabolites that interact with the mammalian metabolome. 
 The central biological question in the Ph.D. project was to understand whether 
and to what extent polyphenol microbial metabolites are able to pass through the 
blood brain barrier after the consumption of strawberries, since according to the 
literature and in vitro experiments they should exert some neurological protection. 
Moreover, in addition to their accessibility in the brain, it was planned to explore 
tissue distribution in other organs in order to get a clearer picture of general tissue 
distribution. Before in vivo trials of the nutritional bioavailability of polyphenol 
microbial metabolites, it was necessary to better characterise the native composition 
of strawberry polyphenols in order to obtain more precise data for dietary 
recommendations and nutritional studies. 
  
 In the first part of the thesis dealing with food chemistry an essential step in 
the study of the biological relevance of polyphenols was to develop a targeted 
metabolomics method for analysis of several classes of phenolic compounds, 
allowing better characterisation of the composition of fruits rich in polyphenols at 
molecular level, with a significant improvement in terms of compounds and time-
consuming analysis.  
 The targeted method developed makes it possible to simultaneously identify 
and quantify more than 150 phenolic compounds in a short chromatographic run, 
with the aim of profiling several foods and beverages using simple sample 
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preparation. The high sensitivity of MRM-based mass spectrometry and the wide 
dynamic range of triple-quadrupole spectrometers provide valuable insight into the 
analysis of complex matrices, in which concentrations span several orders of 
magnitude. Furthermore, it helps to determine the type and amount of dietary 
compounds consumed and the eventual correlation of these with modifications in the 
host system. 
 The application of the targeted method for polyphenols was tested on 
different Fragaria spp., implementing the method with another short run for 
anthocyanins and ellagitannins. Quantitative data at molecular level were provided 
for 56 compounds for the first time. Some of the compounds were identified and 
quantified for the first time in the strawberry. This study represents the most 
comprehensive targeted profiling of strawberry polyphenols, in terms of the number 
of individual compounds identified and quantified.  
 In addition to a general method for analysis of several classes of polyphenols, 
it is also important to focus attention on a specific class of compounds and to provide 
detailed structural identification and quantification. This was done for the class of 
ellagitannins in the strawberry, obtaining the chemical structure of the native form of 
ellagitannins, their concentration, and the ellagitannin profiles during fruit ripening. 
In this part of the project, clarification of the main ellagitannin was achieved for the 
first time after several erroneous identifications, with its isolation and subsequent 
structural characterisation. The most notable results were obtained in the field of 
ellagitannin profiling, with 26 compounds being identified in different Fragaria spp., 
providing structural and quantitative information in the most accurate manner. The 
individual concentrations decreased during ripening in all varieties. 
   
 In the nutritional bioavailability section on the other hand, several limitations 
in terms of knowledge were encountered during the planning of the in vivo part, since 
polyphenol microbial metabolites have only recently gained attention in polyphenol-
based food and nutritional studies, together with the huge growing of interest 
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regarding microbiota. Indeed, limited data were available regarding specific plasma 
or blood concentrations associated with nutritionally relevant consumption.  
 First of all a method for the detection of polyphenol microbial metabolites was 
required. For this purpose a sensitive targeted metabolomics method for the analysis 
of 23 polyphenol microbial metabolites, suitable for application to rat organs (brain, 
heart, liver and kidneys) and biofluids (blood and urine) was developed. The 
development of a purification procedure made it possible to obtain cleaner and more 
concentrated samples, with low limits of detection corresponding to the consumption 
of fruit rich in polyphenols. Considering the variety of matrices which can be treated 
with the same purification and quantitative analysis sample protocol, this method can 
be considered a general method for the simultaneous analysis of several chemically 
different compounds in a complex matrix. 
 Finally, a clear scenario for tissue distribution was obtained in the in vivo trials, 
with the use of a nutritionally relevant dose of metabolites in order to reproduce the 
blood circulating level of these metabolites in vivo. The treatment was carried out by 
intravenous injection, with the aim of bypassing the digestion and gut microflora 
metabolism with its inter-individual variability. Interestingly, the results obtained in 
animals show the simultaneous quantitative profile of some polyphenol microbial 
metabolites for the first time, proving their distribution in the brain and the main 
excretory organs, i.e. the liver and kidneys, and in biofluids (urine and blood).  
 The remarkable results obtained in vivo showed that the brain is one of the 
targets of certain polyphenol microbial metabolites, along with some more specific 
organ-tropism. With effective surgical and analytical protocols and with a 
nutritionally relevant dose injected, notably 10 out of 23 compounds were present in 
significantly increased amounts. 
 This shows an extraordinary improvement in the biological relevance of a diet 
rich in polyphenols and their possible role in neurological protection and the 
prevention of brain ageing. However, on the basis of this data more biological 
experiments now need to prove the real effect of these polyphenol microbial 
metabolites on the brain system in the conditions tested. The results obtained in the 
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brain were surprising, not only because some metabolites were able to pass through 
the blood-brain barrier and arrive in the brain or were already present as basal level, 
but more importantly because such low amounts of dietary metabolites can affect 
homeostasis in such a complex organ and alter its basal level. 
To conclude, these data provide further health implications for the brain-gut 
microbiota axis, showing how polyphenol microbial metabolites could be one of the 
putative connections/messengers between microflora and the brain. Furthermore, 
polyphenol microbial metabolites being the result of the action of the microbiota on 
the dietary intake of polyphenols, it is feasible to consider that these compounds may 
be relevant in the regulation of human health and disease. Their action may lead to a 
reduction in oxidative stress, but more probably to alteration of biochemical and 
physiological processes, also changing the level of endogenous compounds in the 
brain, along with other organs. 
 
 The main follow-up for this Ph.D. project will regard the study of how 
microbial metabolites impact on the primary metabolism of the mammalian system. 
This means studying possible alterations in the homeostasis of different organs. The 
data concerned regard specific biomarkers affected by the intervention (by shifting 
their basal level in a significant manner) and will be directly correlated with the 
presence of polyphenol microbial metabolites, mainly using untargeted metabolomics 
analysis and with major involvement of bioinformatics tools.  
 The future prospects for development of this thesis, adopting a 
multidisciplinary approach, would involve using the detailed information acquired 
from the strawberry polyphenol profile to perform in vitro digestion with faecal 
water, scaling the system and using an amount comparable to the nutritional intake 
and following the production of microbial metabolites. The biological samples of 
fermented faecal water should then be analysed to determine the polyphenol content, 
using the same method developed for analysis of the biological matrix, as already 
tested in preliminary trials. Alternatively, a complete profile of the variety of 
microbial metabolites could be achieved with untargeted metabolomics analysis.  
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 Another interesting future perspective could be to study in detail the plasma 
circulating level of this metabolite after the consumption of strawberries in humans 
and then to directly correlate this with the native composition of polyphenols. From 
the point of view of cell biology and the results obtained from the in vivo study, it 
would be interesting to test whether the concentration used and found in the brain 
would be enough to exert any neuroprotective effect with neuronal cells, glia cells or 
astrocytes against oxidative stress first of all, but also against the more complex 
mechanisms reported in the literature. Of course all these different aspects will 
require the involvement of different skills and make it necessary to set up a 
multidisciplinary team to better address these issues.  
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